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ABSTRACT 
 Autism spectrum disorders (ASD) comprise a heterogeneous group of 
neurodevelopmental disorders characterized by complex genetic etiology. Mutations in 
human APBA2, which encodes for the neuronal adaptor protein Mint2, have been 
genetically linked to ASD patients. APBA2 maps to the distal portion of chromosome 
15q13.1, a region commonly deleted in Prader-Willi and Angelman neurodevelopmental 
disorders and duplicated in cases of autism, making APBA2 an attractive candidate gene 
associated with autism.  Seven novel nonsynonymous coding variants in APBA2 in ASD 
subjects have been identified, five of which were predicted to affect protein function; 
however, they have not been examined functionally. Mint2 belongs to a family of 
neuronal adaptor proteins that are important for synaptic function.  Mint2 interacts 
directly with the cell adhesion protein neurexin-1α, as part of a multi-protein complex 
that acts as a facilitator of neurotransmitter release. Together, these data suggest that 
Mint2 plays an important role in neuronal function, and sequence variations in Mint2 
may alter neuronal dysfunction associated with ASD.  
This thesis examines a point mutation in Mint2, which changes a conserved 
asparagine residue to a serine (N723S) in the second PDZ domain of Mint2, which binds 
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to neurexin-1α. We found the Mint2 N723S mutation did not affect the binding to 
neurexin-1α; however, it dramatically altered neurexin-1α stabilization and trafficking in 
HEK293T cells. While Mint2 wild type greatly increased neurexin-1α at the membrane, 
Mint2 N723S showed a decreased membrane level of neurexin-1α, indicating the steady-
state surface expression of neurexin is affected by the Mint2 N723S mutation.  Also, we 
found that Mint2 N723S decreased neurexin localization in axons and the presynaptic 
terminal in neurons, which correlated with a decrease in synaptogenesis and miniature 
event frequency in excitatory synapses in neurons.  Together, these results suggest that 
Mint2 N723S leads to dysfunction in neuronal development, in part due to alterations in 
intracellular neurexin trafficking and altered synaptic function of Mint2, as potential 
mechanisms that contribute to ASD pathogenesis. 
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CHAPTER ONE: Introduction 	  
Autism spectrum disorder (ASD) overview 
Autism spectrum disorder (ASD) is a heterogenous neurodevelopmental disorder 
with broad pathological and unknown neurobiological etiology.  Autism is diagnosed 
based on three behavioral criteria, namely language impairment, social deficit, and 
repetitive behavior, suggesting that each behavioral abnormality may result from 
different genes associated with different areas of the brain (Happe et al. 2006).  Although 
autism is diagnosed strictly on behavior criteria, other comorbidities, such as mental 
retardation, epilepsy, sleep disorder, and anxiety disorder are often diagnosed in autistic 
individuals, suggesting similar brain dysfunctions are involved in these disorders 
(Herbert 2005).   
Autism has a broad spectrum of clinical manifestations and striking interpersonal 
differences between affected individuals.  Based on studies of thousands of children, the 
field has compiled extensive clinical diagnostic criteria, but the corresponding 
neuropathological diagnostic criteria are lagging behind, partially due to a lack of 
availability of post-mortem brains.  The present studies show that the most consistent 
neuroanatomical abnormality in autism is a usually large brain size and a large 
contribution of white matter to the increase in brain volume (Herbert 2005).  
Epidemiological studies indicate a dramatic rise in autism cases in the recent 
years (Herbert 2005).  Before 1990, autism was considered a rare disorder, affecting 3-4 
in 10,000 individuals.  Currently, autism affects around 3 to 6 in 1000 children and 
mostly males (Muhle et al. 2004), but the gender preference of the disorder is not well 
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understood.  The increased frequency is probably due to a combination of more public 
awareness and broadened diagnostic criteria.  The onset of symptoms starts around three 
years of age, and affected individuals usually require lifelong assistance (Fombonne 
2005). 
 
Genetic association of autism 
The cause of autism is not clear, but genetics certainly play a major role.  Autism 
is the one of the most heritable neurodevelopmental disorder based on twin studies 
(Folstein and Rosen-Sheidley 2001).  The concordance rate of autism for monozygotic 
twins is 70% as compared to 5% in dizygotic twins (Sebat et al. 2007), suggesting that 
genetics contribute a major role in the etiology of autism.  However, the mode of 
inheritance is not well known.   
Despite the strong genetic correlation, not a single gene to date has been identified 
to contribute to a significant number of autism cases, suggesting that other factors are 
involved.  The causes of autism are likely the results from a complex interplay of 
genetics, environment, and experience.  Environmental factors such as exposure to 
teratogens, prenatal viral infections, such as rubella and cytomegalovirus during and after 
pregnancy have been associated with some cases of autism (Muhle et al. 2004). 
 Autism displays a pronounced degree of genetic heterogeneity, which presents a 
major obstacle to research.  Based on linkage studies to identify candidate genes, many 
loci on 20 different chromosomes have been identified to be associated with autism 
(Klauck 2006).  Regions confirmed by multiple linkage studies are on chromosome 1p, 
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5q, 7q, 15q, 16p, 17q, 19p, and Xq (Klauck 2006), which is consistent with the theory 
that many genes are involved and likely leading to common neurodevelopmental 
pathways.  Also, cytogenetic abnormalities in various loci on all chromosomes have been 
identified in more than 5% of affected children (Vorstman et al. 2006).  However, both 
linkage and cytogenetic studies fall short of validating the exact genes that are involved 
in autism, with the exception of some rare syndromic forms of autism, such as Rett 
syndrome, where a single gene has been unambiguously identified to cause autism.   
Based on recent protein interaction networks, autism candidate genes converge to 
three common pathways; synaptic function, chromatin remodeling, and WNT signaling 
(Iossifov et al. 2014)—see Fig. 1.1.  The synaptic function pathway involves proteins that 
are essential for synapse function.  Based on post-mortem brain studies from autism 
patients, no gross anatomical abnormalities were observed in the brain regions that are 
associated with autistic phenotypes.  Therefore, it is more likely that smaller 
computational units such as individual synapses are at fault.  This observation leads to the 
synaptic function pathway.  Various proteins in the synaptic function pathway, such as 
NMDA receptor subunits, CASK, neuroligins, and neurexins have been linked to autism 
(Glessner et al. 2009).  Another study found that genes, such as APBA2, CNTNAP1, and 
CAMK2B are regulated together in autism (Voineagu et al. 2011)—see Fig. 1.2.  These 
genes are involved in synaptic function, vesicular transport, and neuronal projection, 
suggesting that a complex interaction among genes from multiple pathways are involved 
in autism.  
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Proteins in the chromatin-remodeling pathway are involved in transcriptional 
regulation and can alter virtually any neuronal function (Fig. 1.1).  Similarly, the WNT 
signaling pathway can have wide ranging effects as it plays important roles in neuronal 
development and growth.  The interactions are complex.  Not only proteins within a 
common pathway can interact with each other, but proteins between independent 
pathways can also interact.  For example, CTNNB1 (beta-catenin), an important protein 
that regulates neuronal development and growth in the WNT pathway, interacts with 
CHD8 (Chromdomain helicase DNA binding protein 8) in the chromatin remodeling 
pathway.  This interaction further illustrates that autism is not a single-gene disease as 
many proteins from multiple pathways can be involved.  
 
Mint family of adaptor proteins  
Mints are multidomain adaptor proteins that assemble protein complexes for 
dynamic cellular processes in protein trafficking, plasticity, and signaling in neurons 
(Rogelj et al. 2006).  Mammalians have three MINT genes (MINT1-3 or APBA1-3), 
encoded on chromosome 9, 15, and 19, respectively(Okamoto and Südhof 1997, 
Okamoto and Südhof 1998).  Mints are evolutionary conserved, for example, human and 
mouse Mint2 share over 90% sequence homology.  Mint2 arises evolutionarilly later 
compared to Mint1, most likely due to gene duplication of Mint1 to provide redundant 
functions in the complex vertebrate brain.  
Mints 1 and 2 are neuronal specific, while Mint 3 is ubiquitously expressed 
(Okamoto and Südhof 1997).  Mint1 was first identified as a candidate gene for 
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Friedreich’s ataxia (Duclos et al. 1993); however, this association was later proven to be 
false.  Interest in Mints arose when it was found that all Mints bind to the amyloid 
precursor protein (APP) (Borg et al. 1996, Zhang et al. 1997), and misprocessing of APP 
contributes to the pathogenesis of Alzheimer’s disease (AD).  Because of the interaction 
between Mints and APP, the official gene name for Mint proteins are APBA1-3 (APP 
binding family A).  Another group had independently identified Mints as Munc18-
interacting proteins, because of their interaction with Munc18, a synaptic vesicle docking 
protein required for synaptic transmission (Okamoto and Südhof 1997).  However, only 
Mints 1 and 2 can bind to Munc18-1 since Mint3 lacks the Munc18-interacting domain 
(MID) (Okamoto and Südhof 1998).  
  
Structure of Mints 
The Mint family of adaptor proteins are multidomain proteins that consists of a 
divergent amino (N)-terminus and conserved carboxyl (C)-terminus (Fig. 1.3).  Mint1 is 
the only Mints containing the CASK-interacting domain (CID) on the N-terminus.  
Mint1, CASK, and Veli form a tripartite complex that couples presynaptic vesicle 
exocytosis to cell adhesion in neurons (Butz et al. 1998).  Also in the N-terminus, 
neuronal Mints 1 and 2 binds to Munc18-1, an essential synaptic vesicle protein, linking 
Mints to synaptic vesicle exocytosis (Okamoto and Südhof 1997, Ho et al. 2006).  This 
interaction is consistent with Mint knockout analyses, which revealed that Mints 1 and 2 
are critical for presynaptic function (Ho et al. 2006, Ho et al. 2003).  In the conserved C-
terminus, the phosphotyrosine binding (PTB) domain of all three Mints binds to the 
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cytoplasmic tail of APP and alters its proteolytic processing which is centrally involved 
in the pathogenesis of Alzheimer’s disease (Borg et al. 1996, Ho et al. 2008).  Also, the 
PTB domain interacts with phosphatidylinositol biphosphate (PIP2), suggesting that 
Mints are associated with the plasma membrane during vesicle docking before fusion 
(Okamoto and Südhof 1997).  In the C-terminus, the two postsynaptic density-
95/Drosophila discs-large/zona occludens-1 (PDZ) domains bind to various proteins in 
vitro, including neurexin I (Biederer and Südhof 2000), presenilin I (Lau et al. 2000, 
Biederer et al. 2002), and calcium channels (Maximov et al. 1999), which all are 
essential for synaptic functions.  PDZ domains associate with other protein-binding 
motifs to form supramolecular complexes.  The major function of PDZ-containing 
proteins is to act as scaffolds for multi-protein complex assembly.  Structurally, PDZ 
domains recognize a free carboxylate group at the C-terminus of proteins (Sheng and 
Sala 2001).  For example, the PDZ domains of neuronal Mints 1 and 2 recognize the C-
terminus of neurexin I (Biederer and Südhof 2000).  However, it is not known which 
PDZ domain directly interacts with neurexin I.  While the sequences of PDZ domains 
between proteins are highly variable, the PDZ domains of Mints 1 and 2 are highly 
conserved, likely to account for Mints functional redundancy.  Binding ligands of both 
PDZ domains of Mint1 were identified by target-assisted iterative screening (TAIS), a 
phage display-based approach (Swistowski et al. 2009).  The binding histograms indicate 
that the recognition profiles between two PDZ domains are significantly different.  The 
PDZ-2 is more promiscuous and has a high affinity for peptides containing a C-terminal 
valine.  
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Mints function is regulated by an autoinhibition domain in the C-terminus (Long 
et al. 2005, Matos et al. 2012, Xie et al. 2013).  Mint1 binding to its targets is regulated 
by autoinhibition (Long et al. 2005).  The highly conserved C-terminal tail of Mint1 folds 
back to the first PDZ domain, which inhibits target peptide binding.  Our laboratory has 
shown that the C-terminal linker region of Mint1 folds back onto the PTB domain and 
modulates APP processing (Matos et al. 2012).  Similarly, Mint2 has an autoinhibition 
domain that regulates APP binding with its open and close conformations (Xie et al. 
2013).   
The multi-domain nature of Mints allows the assembling of different protein 
complexes to mediate various neuronal functions (Fig. 1.4).  Mint1 can form a tripartite 
complex with CASK and Munc18-1 (Biederer and Südhof 2000).  Mint1 binding to 
Munc18-1 enhances its interaction with CASK.  Mint2 can also interact with neurexin 
and Munc18-1 to form another tripartite complex at the presynaptic membrane.  The 
functional importance of these interactions allows the assembling of different complexes 
for various neuronal functions.  
 
Function of Mints 
All single Mint knockout mice were viable and fertile (Ho et al. 2006).  However, 
Mint1 knockout mice exhibited a significant reduction in body size (Ho et al. 2003), 
which was not observed in Mints 2 and 3 knockout mice (Ho et al. 2006).  Mints 1 and 2 
are involved in postnatal survival as 80% of Mints 1 and 2 double knockout mice died at 
birth.  The surviving 20% mice have lower body weight and abnormal motor function 
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compared to wild type mice (Ho et al. 2006).  Moreover, the surviving mice at 3-4 weeks 
of age exhibit decreased synaptic strength and a decline in presynaptic neurotransmitter 
release machinery (Ho et al. 2006).  
Mints 1 and 2 have redundant domains and functions.  However, they are not 
completely redundant based on the following three findings.  First, in situ hybridization 
data identified that Mints 1 and 2 have different mRNA expression in adult murine brain 
(Nakajima et al. 2001), which suggests differences in tissue-specific promoters and/or 
tissue-specific mRNA degradation.  Mint1 mRNA expression is enriched in the limbic 
system and Mint2 is enriched in the cerebral cortex, entorhinal cortex, and hippocampus 
(Nakajima et al. 2001).   
Second, Mints 1 and 2 are differentially localized to inhibitory and excitatory 
neurons (Ho et al. 2003, Ho et al. 2006).  Mint1 is involved in GABAergic synaptic 
transmission, and deletion of Mint1 in mice alters GABAergic synaptic transmission (Ho 
et al. 2003).  Mint2 is involved in excitatory neurotransmission (Ho et al. 2006, Ho et al. 
2008).  
Third, Mints 1 and 2 have preferential intracellular localizations (Nakajima et al. 
2001).  Mint1 is localized to the somatodendrites and known for its postsynaptic function.  
A previous study has shown that Mint1 is localized in the dendrites to facilitate NMDA 
receptor trafficking to the postsynaptic membrane (Setou et al. 2000).  In contrast, Mint2 
is more involved in the presynaptic terminal.  These different localizations suggest 
differences in binding partners and functions.  However, this does not mean that Mints 1 
and 2 have completely polarized localization in neurons.  Numerous studies indicate that 
	  	  
9	  
Mints 1 and 2 are localized at both presynaptic and postsynaptic terminals and assume 
different functions depending on their location.  Moreover, in vertebrate neurons, Mints 1 
and 2 are concentrated at the Golgi apparatus (Biederer et al. 2002) and localized 
throughout axons and dendrites, strongly suggesting that Mints are involved in protein 
trafficking.   
Mints 1 and 2 also have different temporal expression in the brain.  Mint2 is 
expressed earlier in the brain compared to Mint1 indicating that Mint2 may be involved 
in early brain development compared to Mint1 (Ho et al. 2003).  Behavioral studies 
indicate that Mint2 is involved in normal social development.  Mint2 knockout mice 
displayed conflict avoidance and subordination in competitive feeding situations.  This 
deficit in social interaction supports the role of Mint2 in normal emotional and social 
development (Sano et al. 2009).   
   
Mutation in Mint2 links to autism 
Autism is a neurodevelopmental disorder with a strong genetic component, 
including chromosomal aberrations.  Among all the chromosomes, sex chromosomes and 
the long arm of chromosome 15 have been most frequently altered in autism (Gillberg 
1998).  The most often identified chromosomal abnormality is isodicentric chromosome 
15 or idic(15), an inverted duplication of chromosome 15, in which the extra 
chromosomal material has been duplicated end-to-end like a mirror image (Fig. 1.5).  The 
large extra genetic material accounts for some symptoms found in autism.  It is important 
to note that idic(15) has some autistic-like characteristics, but it is not the same as autism.  
	  	  
10	  
In addition to such large-scale duplication, smaller intrachromosomal duplications of 
chromosome 15 have been reported in autism.  In one family, maternal inheritance of 
15q11-q13 duplication causes autism, but parental duplication of the same region leads to 
a normal phenotype, suggesting that the origin of duplication can be a contributing factor 
(Cook et al. 1997).  In addition to duplication, microdeletion of chromosome 15q11-13 in 
Angelman syndrome causes intellectual disabilities and neurodevelopmental deficits.  
Angelman syndrome is a type of copy number variant with less gene dosage, but it has 
some autism-liked symptoms.  In sum, this evidence strongly suggests that chromosome 
15q11-13 must be tightly regulated as duplication or deletion of genetic material leads to 
autism and neurodevelopmental disorders.  
The 15q11-q13 region spans several hundred thousand base pairs and consists of a 
handful of neuronal genes, including the MINT2 (APBA2) that resides within the 
chromosome region 15q13.1 and 15q13.3 (Fig. 1.5).  Duplication and deletion of this 
region have been implicated in neurodevelopmental disorders (Cook et al. 1997, Babatz 
et al. 2009, Cook et al. 1998, Gillberg 1998, Schroer et al. 1998, Shao et al. 2002, Muhle 
et al. 2004, Christian et al. 2008)— see Fig. 1.5.  
Mint2 copy number variants have been implicated in autism (Babatz et al. 
2009)—see Fig.1.3.  Copy number variants are the insertion or deletion of DNA 
fragments, typically from 50 base pairs up to several megabases.  Insertion of DNA 
fragment would suggest more gene dosage and leads to protein overexpression.  Deletion 
of DNA fragments would suggest less gene dosage and leads a partial knockout 
phenotype.  In chromosome 15, the most common duplications are interstitial 
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dup15q11.2q13.1 and idic(15).  Other less common copy number variants, such as 
duplication and deletion are also found in individuals affected with autism, 
schizophrenia, and mental retardation.  It is important to point out that MINT2  (APBA2), 
located in 15q13.1, is commonly duplicated or deleted in all above cases (Fig. 1.3), 
strongly suggest the importance of Mint2 in normal neuronal development.  
In addition to copy number variants, seven novel non-synonymous sequence 
variants in Mint2 have been identified from 512 autism probands (Babatz et al. 2009).  
The functional consequences of these mutations have not been validated.  It is possible 
that these point mutations may not have any functional consequence that contribute to 
autism since novel non-synonymous mutations have also been identified in 400 control 
individuals.  Here in my work, I have explored the functional impact of some of these 
mutations in HEK293T cells and neurons.   
 
Neurexin family of cell adhesion proteins 
The human NRXN genes encode for neuronal cell adhesion proteins and includes 
three genes in the vertebrate family.  Each gene encodes for a α-neurexin with a long 
extracellular domain and a β-neurexin with a shorter extracellular domain, which are 
generated from independent promoters (Ushkaryov et al. 1994).  In sum, mammalian 
species have six principal forms of neurexins: α-neurexins (1-3) and β-neurexins (1-3) 
generated from two alternative promoters.  Due to alternative splicing, the six individual 
promoters can generate thousands of neurexin isoforms, making neurexin one of the most 
polymorphic proteins in the human proteome.  Diversity in alternative splice variants 
	  	  
12	  
suggest diversity in function.  While the functional consequences of these isoforms are 
not well known, it is likely that various isoforms of neurexins can interact with different 
binding partners to fine tune neuronal functions.  In contrast to mammalian neurexins, 
Drosophila melanogaster and Caenorhabditis elegans only have one α-neurexin, 
suggesting that β-neurexin arose later in evolution.  
Neurexins are conserved evolutionarily and are closely related between different 
species (Missler et al. 1998).  Bovine and rat neurexins exhibit 99% homology in protein 
sequence, suggesting a strong evolutionary pressure for sequence conservation between 
species (Missler et al. 1998).  Neurexins are only found in brain based on northern 
blotting analysis, suggesting that they are neuronal specific proteins (Ushkaryov et al. 
1992).  Since there are many different isoforms due to alternative splicing, it raises the 
question whether these isoforms have brain specific distribution and function.  Based on 
in situ hybridization analysis, neurexins have differential expression in brains with some 
degree of overlap, suggesting that they have differential regulation (Ullrich et al. 1995).  
However, α-neurexin and β-neurexin from the same neurexin gene are very different in 
their distribution, suggesting independent regulation and functional specification.  In 
general, most neurons express multiple isoforms of neurexins (Ullrich et al. 1995).   
 
Structure of neurexins 
  Neurexins are type I single pass transmembrane proteins with a modular 
architecture, suggesting that they were sequentially assembled during evolution.  All 
neurexins have the same basic domain structure.  Structurally, α-neurexin contains a 
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cleavable signal peptide followed by three cassette repeats, a transmembrane domain, and 
an intracellular tail (Missler et al. 1998)—see Fig. 1.6.  α-Neurexin has six laminin-
neurexin-sex hormone (LNS) binding globulin and three epidermal growth factor (EGF) 
domains (Missler et al. 1998).  The three repeats of LNS(A)-EGF-LNS(B) cassette are 
the hallmark of α-neurexin.  β-Neurexins contain only part of the last cassette, therefore 
resulting a much shorter extracellular domain.  The cytoplasmic tails are identical for 
both isoforms.  Neurexins have relatively short cytoplasmic tails with a PDZ-binding 
motif, which are important for interaction with other synaptic proteins CASK (Hata et al. 
1996), syntenin (Grootjans et al. 2000), and Mints (Biederer and Südhof 2000).  The 
PDZ-binding motif is also required for neurexin trafficking (Fairless et al. 2008).  
Deletion of the last four amino acids of PDZ-binding motif traps neurexins in the 
neuronal soma.   
 
Function of neurexins 
Neurexin Iα, the first neurexin identified, binds to α-latrotoxin, a potent 
excitatory neurotoxin from black widow spider to trigger vesicular release at the 
presynaptic terminal (Sugita et al. 1999).  Other neurexin isoforms have later been 
identified because of their sequence homology to neurexin Iα (Ushkaryov et al. 1992).  
Neurexins also bind to neuroligins, dystroglycan, and neurexophilins at the cell 
membrane.  These interactions may or may not require calcium.  Neuroligin binding to 
neurexin (both α- and β-neurexin isoforms) requires extracellular calcium (Missler 
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2003).  Dystroglycan binding to α-neurexin is more favorable with calcium.  
Neurexophilin binding to α-neurexin is calcium-independent.   
Neurexins are involved in synapse formation; e.g., presynaptic β-neurexins 
binding to postsynaptic neuroligin-1 trigger synapse formation (Dean et al. 2003).  Also, 
neuroligins-1 and -2 expressed in non-neuronal HEK293 cells induce presynaptic 
structure in contacting axons (Scheiffele et al. 2000).  However, this finding is 
controversial since different experiments reveal contradicting results.  One study found 
that triple knockdown of neurexins in cultured hippocampal mouse neurons did not alter 
synapse formation between neurons, but inhibited heterologous synapse formation 
(Gokce and Südhof 2013).  Another study found that neurexin triple knockdown neurons 
could still induce proper synapse formation between neurons, suggesting that either 
neurexins are not essential for synapse formation or the knockdown was incomplete.  
Based on these results, whether neurexins are involved in synapse formation or not is up 
to debate.  The contradiction can be explained by the differences in experimental setups 
since cultured neurons have more compensatory mechanisms compared to the simplified 
heterologous cell culture with non-neuronal cells.  What is certain is that the mechanism 
of synapse formation may be more complex than what we think.   
Neurexins are involved in synapse organization and differentiation.  Independent 
of neuroligins, clustering of β-neurexins at the presynaptic terminal recruit cytoplasmic 
scaffold and assemble presynaptic terminals (Dean et al. 2003), suggesting that neurexins 
alone are sufficient to form hemisynapses.  Also, β-neurexins expressed on non-neuronal 
cells can induce postsynaptic clustering of PSD95 in neurons, suggesting that β-neurexins 
	  	  
15	  
are involved in postsynaptic organization (Nam and Chen 2005). Moreover, β-neurexins 
induce postsynaptic differentiation of inhibitory GABAergic and excitatory glutamatergic 
synapse, suggesting that neurexins are involved in synapse specification (Graf et al. 
2004).  
Neurexins are involved in neurotransmission of both excitatory and inhibitory 
synapses (Zhang et al. 2005, Etherton et al. 2009, Zhang et al. 2010).  α-Neurexins triple 
knockout mice have lower release frequency in both excitatory AMPA- and inhibitory 
GABAA-receptor-mediated spontaneous neurotransmitter release (Missler et al. 2003).  
Whole-cell recording in neocortical slices from α-neurexins knockout mice revealed that 
a reduction in NMDA-receptor-mediated postsynaptic current (Kattenstroth et al. 2004).  
β-Neurexins are less essential for neurotransmission as compared to α-neurexins (Born et 
al. 2015), and this is probably because β-neurexins are less abundant in the brain 
(Schreiner et al. 2015).   
Lastly, a more novel function of neurexin in signaling has surfaced recently.  
Neurexin I can bind to adhesion-type G-protein-coupled receptors (GPCRs) on the 
postsynaptic membrane (Boucard et al. 2012).  However, the functional significance of 
this interaction is not well known.  In summary, neurexins are involved in synapse 
formation, synapse differentiation, synaptic transmission and signaling. 
α-Neurexins are essential for postnatal survival as triple knockout (KO) of all 
three α-neurexins dramatically reduces postnatal survival rate in mice.  This lethality is 
caused by the loss of Ca2+ channel function in the absence of α-neurexins, which are 
essential for Ca2+ channel organization at the presynaptic release site.  Even single α-
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neurexin KO mice exhibit impaired survival rate, which suggests that α-neurexins have 
essential but redundant functions.  Also, these mice exhibited altered synaptic 
transmission.  However, synaptic morphology appeared to be normal.  Another study 
found that mouse neurexin Iα deletion causes electrophysiological and behavioral 
changes consistent with some features of cognitive impairments (Etherton et al. 2009).  
 
Mutations in neurexin links to autism   
Altered synaptic function has emerged as a strong basis for impaired cognition 
and cause for ASD which is supported by the prevalence of highly penetrant human 
mutations in genes such as neurexin I and neuroligins, which are associated with synaptic 
structure and function (Feng et al. 2006, Kim et al. 2008, Zoghbi and Bear 2012, Südhof 
2008). The human NRNX1 gene, located on chromosome 2p16.3 is one of the largest 
genes in the genome.  Due to the recent advancement in high throughput array-based 
genome screening technologies, many rare copy number variants have been identified in 
large cohort population (Diaz de Stahl et al. 2008).  Notably, copy number variants in 
NRXN1, NLGN3, and NLGN4 that are involved in synapse structure and function have 
been identified (Kumar and Christian 2009).   
Copy number variants (CNVs) in the human NRXN1 gene have been genetically 
linked to autism and schizophrenia (Rujescu et al. 2009).  Large de novo copy number 
variant contributes to 10% of autism spectrum disorders (Sebat et al. 2007, Zhao et al. 
2007, Weiss et al. 2008).  In addition, other chromosomal abnormalities such as 
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rearrangement in NRXN1, de novo heterozygous deletion of NRXNI, and rare sequence 
variants in β-NRXN1 have been associated with autism (Kim et al. 2008).  
 
Thesis rationale 
ASDs are heterogeneous neurodevelopmental disorders with a broad pathological 
or neurobiological etiology.  Chromosome 15q11-q13 has been identified as a strong 
candidate region for autism susceptibility based on the frequent occurrence of 
chromosomal abnormalities and numerous linkage and genome-wide association studies 
(Mann et al. 2004, Wang et al. 2004).  APBA2, also known as MINT2, is located at the 
distal region of 15q11-q13, which spans several hundred thousand base pairs and consists 
of a handful of neuronal genes.  MINT2 encodes for a neuronal adaptor protein that is 
involved in various important synaptic function.  Mint2 is implicated as an important 
mediator of ASDs and neuropsychiatric phenotypes based on several lines of evidence.  
First, the MINT2 gene maps to the distal portion of chromosome 15q13.1, a region 
commonly deleted in Prader-Willi and Angelman syndromes (neurodevelopmental 
disorders) and duplicated in cases of autism (Babatz et al. 2009), suggesting that the 
appropriate gene dosage of MINT2 is important for neuronal development and brain 
function. Second, several studies have independently identified copy number variants 
(CNVs) in the MINT2 gene in autism (Iossifov et al. 2014, De Rubeis et al. 2014).  Third, 
seven nonsynonymous coding variants have been identified in the MINT2 gene associated 
with autism (Babatz et al. 2009).  Lastly, Mint2 interacts directly with neurexin I 
(NRXN1), an ASD gene, as part of a multi-protein complex that acts as a facilitator of 
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neurotransmitter release at the synapse (Südhof 2008).  Neurexin Iα deletion leads to 
electrophysiological and behavioral changes that contribute to cognitive impairments that 
are associated with autism (Etherton et al. 2009).  Interestingly, Mint2 binds to neurexin I 
to stabilize synapse assembly (Biederer and Südhof 2000).  Together, these data strongly 
suggest that copy number and sequence variations in Mint2 may contribute to neuronal 
dysfunction in autism.  Despite the central importance of neurexin, little is known about 
the functional role of Mint2-neurexin interaction and its association to autism.  Therefore, 
I hypothesized that Mint2-neurexin plays an important role in neuronal development and 
function and alterations of this interaction may contribute to ASD pathogenesis.   
For this study, the effects of Mint2 copy number and Mint2 ASD sequence variant 
N723S in neuronal development and function were examined (Fig. 1.7).  Copy number 
variants are the duplication or deletion of DNA, which leads to more or less genetic 
material, respectively.  Both types of Mint2 copy number variants were studied.  Mint2 
copy number variant (duplication of DNA) was mimicked by Mint2 overexpression in 
wild type neurons.  Mint2 copy number variant (deletion of DNA) was mimicked by 
Mint2 knockout in Mint-deficient neurons.  Mint2 ASD sequence variant N723S was also 
studied in Mint-deficient neurons.  The study found that Mint2 copy number variants 
(duplication and deletion of Mint2) and Mint2 N723S sequence variant lead to deficits in 
neuronal development and synaptic function.  
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Figure 1.1: Candidate genes for autism spectrum disorder (ASD) and intellectual disability 
(ID) are converged into three common molecular pathways, chromatin remodeling, Wnt 
signaling, and synaptic function. 
In the synaptic function pathway, Mint1 (APBA1), neurexin I (NRNX I), and neuroligin (NLGN I) 
among others were pulled out from the screen.  De novo truncation mutations are in red nodes.  
Missense mutations are in blue nodes.  Number of cases is indicated by the size of the node.  
Figure from Krumm, 2013.  
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Figure 1.2: Autism candidate genes are co-expressed in modules. 
Correlation module showing genes, such as APBA2, CNTNAP1, CAMK2B and many others are 
co-regulated in autism.  These genes are involved in synaptic function, vesicular transport, and 
neuronal projection, suggesting that a complex interplay of many genes from multiple pathways 
are involved in autism.  Figure from Voineagu, 2011.  
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Figure 1.3: Structure of Mints. 
The human Mint family of adaptor proteins are multidomain proteins that consists of a divergent 
amino (N)-terminus and conserved carboxyl (C)-terminus.  Mint1, the largest of all Mints, has the 
CASK-interacting domain (CID) in the N-terminus.  Also in the N-terminus of Mints 1 and 2, the 
Munc-interacting domain (MID) binds to Munc18, an essential synaptic vesicle protein that links 
Mints to synaptic vesicle exocytosis.  In the conserved C-terminus, the phosphotyrosine binding 
(PTB) domain of all three Mints bind to the cytoplasmic tail of the APP and alter its proteolytic 
processing which is centrally involved in the pathogenesis of Alzheimer’s disease.  All Mints 
have two postsynaptic density-95/Drosophila discs-large/zona occludens-1 (PDZ) domains that 
bind to various proteins in vitro, including neurexin I, presenilin I, and calcium channels.  Amino 
acid residue numbers are indicated on the end of each Mint protein.  
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Figure 1.4: Diagram of possible interactions of Mints 1 and 2 with other synaptic proteins. 
Schematic diagram showing that Mints 1 and 2 can form multi-molecular complexes with other 
synaptic proteins, such as CASK, Munc18 (M18), and neurexin on the presynaptic membrane.  
The diagram on the left showing that neurexin (embedded in the plasma membrane) binds the 
PDZ domains of Mint1, which also interacts with Munc18 and CASK.  The diagram in the 
middle showing that neurexin binds to the PDZ domains of Mint2, which also interacts with 
Munc18.  The diagram on the right showing that neurexin binds to the PDZ domain of CASK, 
which also interacts with Mint1 and Munc18.  The diversity of these multi-molecular complexes 
suggests diversity in function.  Figure from Biederer, 2000.   
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Figure 1.5: Diagram of chromosome 15q13 region and  examples of MINT2 (APBA2) copy 
number variants found in autism, schizophrenia, and mental retardation.   
An ideogram showing chromosome 15 and the genes (in blue) that are located in the 15q13 
region.  The MINT2 gene (APBA2) is located in 15q13.1—highlight in yellow.  The diagram 
showing different examples of copy number variants in chromosome 15.  Copy number variants 
are the insertion or deletion of DNA fragments, typically from 50 base pairs up to several 
megabases.  Insertion of DNA fragment would suggest more gene dosage and leads to protein 
overexpression.  Deletion of DNA fragments would suggest less gene dosage and leads a partial 
knockout phenotype.  The most common duplications are interstitial dup15q11.2q13.1 and 
idic(15).  Other less common copy number variants, such as duplication (in green) and deletion 
(in red) are also found in individuals affected with autism, schizophrenia (SZ), and mental 
retardation (MR).  Figure from Babatz, 2009.  
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Figure 1.6: Schematic diagram of α-Neurexins and β-Neurexins structure. 
α-neurexin starts with a cleavable signal peptide (SP) followed by three cassette repeats (marked 
I, II, and III), an O-linked carbohydrate modification (CH), a transmembrane domain (TMR), and 
an intracellular tail.  α-Neurexin has six LNS (laminin-neurexin-sex hormone binding globulin) 
and three EGF (epidermal growth factor) domains.  The three repeats of LNS(A)-EGF-LNS(B) 
cassette are the hallmark of α-neurexin.  β-neurexins contain only part of the last cassette, 
therefore resulting a much shorter extracellular domain.  Regions of alternative splicing sites are 
indicated with arrows.  The cytoplasmic tails are identical for both isoforms.  Figure from 
Missler, 1998. 
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Figure 1.7: A schematic diagram of the projection outline to determine the effects of Mint2 
copy number and sequence variant Mint2 N723S in neuronal development and function. 
Mint2 copy number variant was emulated by the overexpression of Mint2 protein in wild 
type neurons.  Mint2 N723S sequence variant was studied in Mint-deficient (in the 
absence of Mints 1-3) neurons with exogenous expression of GFP-tagged Mint2 N723S.  
Note that Mint-deficient neurons were used because Mints have redundant function.  
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CHAPTER TWO: Materials and Methods 
 
Plasmids  
All twelve nonsynonymous Mint2 mutations were made from pEGFP-C3-Mint2 by 
QuickChange Site Directed Mutagenesis (Agilent Technologies). The Mint2 PDZ1/2 
truncation mutant (Mint2 ΔPDZ of 547 amino acids) was PCR amplified from pEGFP-
C3-Mint2 and subcloned into pEGFP-C3.  Afterwards, pEGFP-Mint2 wild type and 
mutants were digested with NheI and BamHI and subcloned into the lentiviral vector 
pFUW individually to make the recombinant lentiviral constructs.  All plasmids were 
verified by sequencing. GST-neurexin I expression construct and pSyn5-E-mCherry-
Neurexin Iα were kind gifts of Dr. Thomas Biederer (Tufts University, Boston, MA) and 
Dr. Markus Missler (Münster University, Germany), respectively.  I also thank Dr. 
Anthony Boucard (Avandia Instituto Politecnico Nacinoa, Mexico) for the following 
plasmids:  pCMV5-FLAG-neurexin Iα, pCMV5-FLAG-neurexin Iβ, pN1-mVenus, and 
pCMV5-neuroligin IΔAB-mVenus. 
 
Primary neuronal cultures and lentiviral infections  
Primary neuronal cultures were prepared from C57B6 (Jackson Laboratory) or CD1 
(Charles River Laboratories) wild type or M1-/-; fM2/fM2; M3-/- (MINT1 and MINT3 
double knockout, MINT2 conditional floxed knockout) newborn mouse pups of either 
sex.  Dissociated brain tissues were trypsinized for 10 minutes (min) at 37°C and plated 
onto matrigel-coated (BD Bioscience, catalog # CB-40234) plates or coverslips (Ho et al. 
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2006, Ho et al. 2008).  Cultured neurons were maintained in a humidified incubator with 
5% CO2 at 37°C.  All animal experiments were performed in agreement with the Boston 
University Institutional Animal Care and Use Committee Guideline.  Recombinant 
lentiviruses were generated in human embryonic kidney 293T (HEK293T) cells by 
cotransfection of pFUW-EGFP-ΔCre (a control vector without cre recombinase), pFUW-
EGFP-Cre, pFUW-EGFP-Mint2 wild type, pFUW-EGFP-Mint2 N723S, or pFUW-
EGFP-Mint2 ΔPDZ with viral enzymes and envelope proteins (pRSV/REV, 
pMDLg/RRE, and pCMV-VSVG) using FuGENE6 (Promega) (Ho et al. 2006, Ho et al. 
2008).  The initial media was changed into neuronal growth media after 8 hours (h) of 
transfection.  Lentivirus-containing conditioned media was harvested after 48 h, 
centrifuged at 500 × g for 10 min at 4°C to remove cell debris, and stored at -80°C.  
Primary neuronal cultures from wild-type newborn pups were treated with either 
lentiviral control EGFP-ΔCre or EGFP-Mint2 wild type.  Primary neuronal cultures from 
M1-/-; fM2/fM2; M3-/- newborn pups were treated with either lentiviral control EGFP-
ΔCre, EGFP-Cre alone, or EGFP-Cre together with EGFP-Mint2 wild type, EGFP-Mint2 
N723S, or EGFP-Mint2 ΔPDZ.  
 
Transient transfection of cell lines   
HEK293T or COS-7 cells plated on 18 mm glass coverslips (Electron Microscopy 
Science, catalog # 7222-01) or tissue culture plates were grown to 70-80% confluency in 
10% fetal bovine serum (Atlanta Biologicals) in DMEM (Invitrogen).  Cells were 
transfected with Fugene6 reagent (Promega, catalog # PR-E2692).  The DNA to Fugene6 
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ratio is 0.5 µg of DNA to 1.5 µl of Fugene6 for one well on a 12-well plate.  48 h post-
transfections, cells on coverslips were fixed in 4% paraformaldehyde (Thermo Fisher 
Scientific, catalog # 28908) for immunocytochemistry.  Cells on tissue culture plates 
were harvested with 2× reducing sample buffer with 10% β-mercaptoethanol for western 
blotting analysis.  
 
Transient transfection of primary hippocampal neurons  
Cultured hippocampal neurons at 7 or 9 days in vitro (DIV) were plated on 18 mm glass 
coverslips coated with matrigel and transfected with Lipofectamine 2000 transfection 
reagent (ThermoFisher Scientific, catalog # 11668027).  DNA (1 µg) was added to 100 µl 
of Neurobasal media.  In another tube, 6 µl of Lipofectamine 2000 transfection reagent 
was added to 100 µl of Neurobasal media.  Both mixes were incubated at room 
temperature for 5 min.  Then, the Lipofectamine transfection mix was added to the DNA 
mix and incubated for 20 min at room temperature.  Neuronal conditioned media were 
saved and replaced with 500 µl of pre-warmed Neurobasal media.  After 20 min of 
incubation, 200 µl of the DNA-Lipofectamine-neurobasal mix were added to neurons and 
incubated at 37°C for 30 min.  After incubation, neurons were washed twice with 1 ml of 
pre-warmed Neurobasal media and replaced with the saved conditioned media.  48 hours 
post-transfection, neurons on coverslips were fixed with 4% paraformaldehyde for 
immunocytochemistry. 
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Co-immunoprecipitation 
pCMV-APP was transfected together with GFP-tagged Mint2 wild type or Mint2 ASD 
mutations in HEK293T cells.  48 h after transfection, cells were washed with cold 
phosphate-buffered saline (PBS) and lysed.  Lysates were solubilized for 30 min at 4°C 
and centrifuged for 10 min at max speed in a tabletop centrifuge.  10% of the supernatant 
were removed for Western blotting analysis as input.  To the remaining 90% supernatant, 
rabbit anti-GFP antibody (1:500) was added and incubated overnight at 4°C.  Protein A 
beads (Thermo Scientific, Catalog # 53142) were added for 2 h at 4°C.  After binding, 
beads were washed thoroughly and 2× reducing sample buffer with 10% β-
mercaptoethanol were added for Western blotting analysis. 
 
GST pulldown 
GST fusion neurexin I proteins were expressed in the BL21 (DE3) strain of E. coli and 
immobilized with glutathione sepharose beads (GE Healthcare, Catalog #17-0756-01) 
using a standard procedure.  HEK293T cells were transfected with either GFP-Mint2 
wild type or N723S.  48 h after transfection, lysates were solubilized in buffer containing 
50 mM Tris-HCl, pH 7.2, 1 mM EDTA, 150 mM NaCl, 1% NP-40 and proteinase 
inhibitors.  Lysates were rocked in 4°C for 30 min and centrifuged at 10 rpm at 4°C for 
10 min.  The supernatant was collected and incubated with 50% slurry of purified GST 
fusion neurexin I immobilized on glutathione sepharose beads for 2 h at 4°C.  After 
incubation, beads were thoroughly washed three times with the same buffer as above and 
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2× reducing sample buffer with 10% β-mercaptoethanol was added.  Samples were heat 
denatured and subjected to Western blotting analysis. 
 
Native gel electrophoresis 
HEK293T cells were first washed with PBS and solubilized in 300 µl/well of 
NativePAGE 4× sample buffer (Novex by Life Technologies, Catalog # BN2008) with a 
final concentration of 10% DDM (Novex by Life Technologies, Catalog # BN2005).  
After 15 min incubation on ice, cell lysates were homogenized by pipetting multiple 
times and centrifuged at 20,000 × g for 30 min at 4°C to separate the supernatant from the 
pellet.  To prepare the loading sample, 5% G-250 sample additive was added to the 
supernatant so that the final G-250 concentration is 25% of detergent concentration. 
Native-PAGE Bis-tris gels electrophoresis was performed following the manufacture’s 
protocol (Novex by Life technologies, Catalog # BN1002).  Protein complexes were 
detected by Western blot.  
 
Membrane and soluble neurexin fractionation  
HEK293T cells transfected on a 10-cm dish were washed with 1× PBS and stored at -
80°C (up to 3 months).  Cells were warmed up in a 37°C water bath for 30 seconds (sec) 
to induce freeze-fracture of the cell membrane and homogenized with a syringe in 1.5 ml 
of 0.1% BSA in 1× PBS with proteinase inhibitors (aprotinin, pepstatin, and leupeptin).  
Fifty µl of this initial lysate was set aside for western blot analysis.  The remaining lysate 
was spun down at 5,000 rpm for 5 min in a 4°C tabletop centrifuge to remove large 
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cellular debris.  The supernatant was transferred to an ultracentrifuge tube (Beckman 
Coulter, catalog # 344057) and centrifuged at 135,000 × g for 1 h at 4°C.  The 
supernatant “soluble” fraction was removed to a new tube and set aside for western blot 
analysis.  The remaining pellet was solubilized in a buffer containing 1% Triton X-100, 2 
mM CaCl2, 2 mM MgCl2, 150 mM NaCl, 0.1% EDTA, and proteinase inhibitors and 
extracted for 2 h at 4°C.  After extraction, the lysate was centrifuged at 100,000 × g for 1 
h at 4°C.  The supernatant “membrane” fraction was removed to a new tube for western 
blot analysis and the pellet “insoluble” fraction was discarded.  Protein levels of all three 
fractions (total, soluble, and membrane) were quantified by immunoblotting analyses. 
 
Immunocytochemistry and electron microscopy 
Primary hippocampal neurons at 14 DIV were fixed with 4% paraformaldehyde at room 
temperature for 8 min, permeabilized and blocked in 10% goat serum and 0.1% saponin 
in PSB.  Cells were incubated with primary antibodies in blocking buffer (10% goat 
serum in PBS) at 4°C overnight.  Following PBS washes, cells were incubated with either 
goat anti-mouse or goat anti-rabbit IgG secondary antibodies conjugated to Alexa Fluor-
546 or -647 (Invitrogen) in blocking buffer for 1 h at room temperature.  Following PBS 
washes, coverslips were mounted with ProLong Gold Antifade Mountant with DAPI 
(Invitrogen) and imaged with a Carl Zeiss LSM700 confocal microscope.  For electron 
microscopy, hippocampal neurons plated on coverslips at 14 DIV were fixed with 2.5% 
glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4.  Sample processing and image 
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acquisition were done by Dr. Xinran Liu (Yale University).  Images were analyzed 
according to a standard protocol (Rosahl et al. 1995).  
 
Electrophysiology 
The spontaneous excitatory synaptic transmission was recorded from hippocampal 
neurons at 14–17 DIV via whole-cell voltage-clamping in the presence of 1 µM 
tetrodotoxin, 50 µM D-2-amino-5-phosphonovaleric acid, and 20 µM bicuculline.  The 
pipette was filled with electrode solution containing 105 mM Cs-MeSO3, 10 mM CsCl, 5 
mM NaCl, 10 mM HEPES, 0.2 mM EGTA, 4 mM Mg-ATP, and 0.3 mM Na2GTP, pH 
7.4 (300 mOsm—adjusted with 1M sucrose).  Recordings were obtained using an 
Axopatch 200A amplifier and 1440 Digitizer and analyzed with Clampfit software 
(Molecular Devices).  
 
Heterologous synapse formation assay 
Primary hippocampal neuronal cultures from M1-/-; fM2/fM2; M3-/- newborn pups were 
treated with either lentiviral EGFP-Cre alone, EGFP-Cre with EGFP-Mint2 wild type, 
EGFP-Mint2 N723S, EGFP-Mint2 ΔPDZ or EGFP-Mint2 wild-type with EGFP-Mint2 
N723S (heterozygous) at 3 DIV.  COS-7 cells were transfected with mVenus control or 
NL1-mVenus using FuGene-6 (Roche) when neurons are at 10 DIV.  48 h after 
transfection, COS-7 cells were seeded onto the treated hippocampal neurons for 48 h of 
co-culturing to induce synapse formation at 12 DIV.  After 2 days of co-culturing, cells 
were fixed with 4% paraformaldehyde and labeled with rabbit anti-synapsin P610 
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antibody and Alexa-546 secondary antibody.  Z-stacked images were captured with a 
Carl Zeiss LSM700 confocal microscope and converted to the sum of slices using the 
ImageJ program (US National Institutes of Health).  The degree of synapse formation 
between treatments was quantified as the ratio of presynaptic synapsin in neurons to 
postsynaptic mVenus in COS-7 cells.  Briefly, an image of a NL1-mVenus transfected 
COS-7 cell was selected and the cell membrane (where most of the NL1-mVenus 
expression is localized) was traced in ImageJ program.  The same trace was transferred to 
the synapsin image using the ROI Manager.  The signal intensities for both images 
(synapsin and mVenus) were measured with the ImageJ and the ratio of signal intensity 
(synapsin/mVenus) was calculated for each treatment.  
 
Fluorescent recovery after photo bleaching (FRAP) 
Primary wild-type hippocampal neurons on glass bottom plate (In Vitro Scientific, 
Catalog # P06-20-1.5-N) infected with lentiviral Mint2 wild type or Mint2 N723S at 3 
DIV were used for FRAP experiment at 14 DIV.  A 488 nm diode laser was used to 
photobleach GFP-Mint2 enriched Golgi regions with 100% laser power for 3 consecutive 
cycles.  Recovery fluorescence was acquired with 1% laser power and imaged every 5 
sec for 170 sec.  Analysis was generated by the FRAP module (Zen software, Zeiss).   
 
Time-lapse imaging 
Primary hippocampal neuronal cultures from M1-/-; fM2/fM2; M3-/- newborn pups plated 
on glass bottom plates (In Vitro Scientific, Catalog # P06-20-1.5-N) were treated with 
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either lentiviral EGFP-Cre and EGPF-Mint2 wild type or EGPF-Mint2 N723S at 3 DIV. 
Images of neuronal processes expressing GFP-tagged Mint2 proteins were captured every 
1 sec for 60 sec in a 37°C chamber with 5% CO2 at 14 DIV.  No visible signs of 
photodamage were observed because low laser power was used during imaging.  
Kymographs of straighten processes were created with ImageJ.  The resulting kymograph 
shows distance travelled (on the x-axis) and time elapsed (on the y-axis).   
 
Immunoblotting analysis  
For immunoblotting analysis of neurons and cell lines, cells were washed with PBS and 
lysed with 2× reducing sample buffer with 10% β-mercaptoethanol.  Harvested lysate 
was sonicated and boiled for 10 min.  SDS-PAGE was performed using a standard 
technique.  Proteins were transferred to 45 µm pore size nitrocellulose blotting membrane 
(GE Healthcare, catalog # 10600002) using a standard wet transfer system.  The 
membrane was blocked with 5% milk in 1× Tris-buffered saline with Tween 20 (TBST) 
and probed with the appropriate primary antibody in the same blocking buffer overnight 
at 4°C.  The membrane was thoroughly washed with 1× TBST and probed with either 
goat anti-rabbit or goat anti-mouse horseradish peroxidase (HRP) conjugated secondary 
antibody for 1 h at room temperature.  After washing to remove the unbounded secondary 
antibodies, the membrane was incubated with ECL Prime Western Blotting Detection 
Reagent (GE Healthcare, catalog # 45-002-401) and XO-MAT film (Kodak) was 
exposed.  Signal intensities were quantified with Image Studio Software (LiCor) and 
normalized for GAPDH or α-tubulin as a loading control on the same blot.   
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Statistical analysis 
All error bars shown are mean ± standard error of the mean (SEM). Statistical 
significance between treatments was determined by pairwise Student’s t test or One-Way 
ANOVA followed by Dunnett multiple comparison test (Prism 6, Graphpad). 
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Table 2.1:  Plasmids 
 
Description Vector backbone Method of cloning  
Mint2 R4Q pCMV3-EGFP Site-directed mutagenesis 
Mint2 G96_T98del-insA pCMV3-EGFP Site-directed mutagenesis 
Mint2 A137V pCMV3-EGFP Site-directed mutagenesis 
Mint2 H150D pCMV3-EGFP Site-directed mutagenesis 
Mint2 Q436H pCMV3-EGFP Site-directed mutagenesis 
Mint2 T660M pCMV3-EGFP Site-directed mutagenesis 
Mint2 N723S pCMV3-EGFP Site-directed mutagenesis 
Mint2 P22T pCMV3-EGFP Site-directed mutagenesis 
Mint2 P105L pCMV3-EGFP Site-directed mutagenesis 
Mint2 S114L pCMV3-EGFP Site-directed mutagenesis 
Mint2 M476V pCMV3-EGFP Site-directed mutagenesis 
Mint2 A632T pCMV3-EGFP Site-directed mutagenesis 
Mint2 ΔPDZ pCMV3-EGFP Site-directed mutagenesis 
Mint2 WT pFUW Restriction-based 
Mint2 R4Q pFUW Restriction-based 
Mint2 G96_T98del-insA pFUW Restriction-based 
Mint2 A137V pFUW Restriction-based 
Mint2 H150D pFUW Restriction-based 
Mint2 Q436H pFUW Restriction-based 
Mint2 T660M pFUW Restriction-based 
Mint2 N723S pFUW Restriction-based 
Mint2 P22T pFUW Restriction-based 
Mint2 P105L pFUW Restriction-based 
Mint2 S114L pFUW Restriction-based 
Mint2 M476V pFUW Restriction-based 
Mint2 A632T pFUW Restriction-based 
Mint2 ΔPDZ pFUW Restriction-based 
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Table 2.2: Antibodies 
 
Name Source Catalog # Host Dilution Usage 
Primary Antibodies 
Alpha 1 sodium 
potassium ATPase Abcam Ab7671 Mouse 1:200 WB 
APP Dr. Thomas Südhof U955 Rabbit 1:1000 WB 
APP 2C11 Millipore MAB374 Mouse 1:1000 ICC 
FLAG M2 Sigma F3165 Mouse 1:1000 WB 
GAPDH Millipore MAB374 Mouse 1:5000 WB 
GFP Dr. Thomas Südhof 437B Rabbit 1:1000 WB 
GFP Synaptic System 132 002 Rabbit 1:1000 WB 
GM130 BD Biosciences 610822 Mouse 1:1000 ICC 
MAP2 Millipore/Chemicon AB5622 Rabbit 1:1000 ICC 
mCherry Abcam ab167453 Rabbit 1:500 ICC 
Mint2 Sigma M3319 Rabbit 1:1000 WB 
Munc18 Dr. Thomas Südhof K329 Rabbit 1:500 WB 
Neurexin I Synaptic Systems 174 103 Rabbit 1:1000 WB 
PSD-95 Abcam ab2723 Mouse 1:1000 ICC 
SMI-312 Convance SMI-312R Mouse 1:1000 ICC 
Synapsin Dr. Thomas Südhof P610 Rabbit 1:500 ICC 
Synaptobrevin 2 Synaptic Systems 104 211 Mouse 1:1000 ICC 
Tubulin (DM1A) Cell Signaling 3873 Mouse 1:1000 ICC 
Secondary Antibodies 
Anti-mouse Alexa 
546 Invitrogen A-11030 Goat 1:500 ICC 
Anti-rabbit Alexa 
546 Invitrogen A-11010 Goat 1:500 ICC 
Anti-mouse Alexa 
647 Invitrogen A-21236 Goat 1:500 ICC 
Anti-rabbit Alexa 
647 Invitrogen A-21070 Goat 1:500 ICC 
Anti-mouse HRP 
Cell Signaling 
Technology 7076 Goat 1:5000 WB 
Anti-rabbit HRP 
Cell Signaling 
Technology 7074 Goat 1:5000 WB 
.
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CHAPTER THREE: Characterization of autism-associated Mint2 mutations and 
their roles in neuronal development 
 
Introduction 
Autism is a neurodevelopmental disorder characterized by impairment in social 
interaction and language ability.  MINT2 is an autism candidate gene based on its strong 
genetic associations.  The MINT2 gene (also named APBA2) is located in the 15q11-q13 
locus.  Mutations in this locus have been frequently reported in autism (Cook et al. 1997, 
Babatz et al. 2009, Cook et al. 1998, Gillberg 1998, Schroer et al. 1998, Shao et al. 2002, 
Muhle et al. 2004, Christian et al. 2008).  
The neuronal adaptor protein Mint2 (also named APBA2) is a multidomain 
protein with numerous binding partners.  In the N-terminus, the Munc-interacting domain 
(MID) domain binds to Munc18-1 and facilitates vesicular fusion at the presynaptic 
terminal during neurotransmission (Okamoto and Südhof 1997).  In C-terminus, the PTB 
domain binds to APP and modulates its metabolism associated with Alzheimer’s disease 
(Tomita et al. 1999, Araki et al. 2003, Sano et al. 2006).  The two PDZ domains in the C-
terminus bind various proteins in vitro, including neurexin I (Biederer and Südhof 2000), 
presenilin I, and calcium channels (Maximov et al. 1999).  These interactions strongly 
indicate Mint2 involvement in synapse function and neurodegeneration.  In addition to in 
vitro studies, physiological functions of Mint2 have been examined in Mint2 knockout 
mice.  Mints are involved in postnatal survival as 80% of Mint1/2 double knockout mice 
died at birth, but single knockout mice of either Mints survived normally, suggesting that 
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Mints are functionally redundant.  Mint2 is also involved in normal emotional and social 
development (Sano et al. 2009).  Mint2 knockout mice displayed conflict avoidance and 
subordination under competitive feeding situation.  However, very little is known about 
Mint2 function in neurodevelopment and whether Mint2 contributes to autism. 
Therefore, to determine whether Mint2 plays a role in neuronal development that 
may contribute to autism, I examined Mint2 function in both axonal and dendritic 
development.  These analyses serve as a preliminary assessment to determine whether 
Mint2 is involved in neuronal growth.  Based on histological studies of postmortem 
brains from autistic patients, neuronal overgrowth seems to be one of the contributing 
factors.  In addition, I examined the effect of Mint2 copy number variant and specifically 
the ASD sequence variant N723S in axonal and dendritic development.  The Mint2 copy 
number variant was examined by overexpression of Mint2 protein in wild-type neurons.  
The Mint2 ASD sequence variant N723S was studied in Mint-deficient neurons infected 
with GFP-Mint2 N723S lentivirus.   
 
 Results 
Mint2 ASD mutants do not alter protein expression in HEK293T cells 
A previous study has found seven nonsynonymous Mint2 mutations associated 
with ASD (Babatz et al. 2009) (Fig. 3.1A).  Five of these seven coding variants in Mint2 
were predicted to affect protein function (Babatz et al. 2009); however, these mutants 
have not been examined functionally.  To determine whether Mint2 ASD mutants alter 
Mint2 protein expression, I generated a panel of lentiviral GFP-Mint2 mutants each 
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bearing one of the seven human Mint2 autism mutations or five control variants within 
the rat Mint2 cDNA since all the mutated residues are fully conserved between human 
and rat Mint2 (Fig. 3.1A).  I evaluated whether Mint2 mutants were properly expressed in 
vitro by transfecting Mint2 wild type or mutants in HEK293T cells and immunoblotted 
for the GFP-tagged Mint2 protein (Fig. 3.1B).  Since all the Mint2 plasmids are driven by 
the same CMV promoter, protein expression can be compared between wild type and 
mutations.  Protein expression profile of GFP-Mint2 showed that the Mint2 mutants 
expressed at similar levels compared to Mint2 wild type suggesting that these Mint2 
mutants did not disrupt Mint2 expression.  GFP-tagged Mint2 was probed with anti-GFP 
antibodies.  α-Tubulin was used as a loading control on the same blot. 
 
Primary screening of Mint2 ASD mutants  
Previously, Babatz and colleagues screened 512 autism probands and identified 
seven unique ASD Mint2 mutations and five control Mint2 mutations (Fig. 3.1A).  Mint2 
interacts with APP and regulates its processing.  Several studies have shown a link 
between altered APP metabolism and abnormal intracellular accumulation of amyloid-β 
(Aβ) peptide in children and adults with autism (Frackowiak et al. 2013, Bailey et al. 
2008, Sokol et al. 2006, Wegiel et al. 2012).  In addition, APP is involved in neuronal 
development, neurogenesis, differentiation, and migration (Nicolas and Hassan 2014).  
First, to determine whether Mint2 ASD mutants alter APP protein expression, I co-
transfected APP together with Mint2 mutants in HEK293T cells.  I immunoblotted the 
harvested lysates for GFP-Mint2, APP, and GAPDH and found that Mint2 ASD mutants 
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did not alter APP protein expression (Fig. 3.2A).  Next, to determine whether Mint2 ASD 
mutants alter APP binding, I have screened all Mint2 mutations in co-
immunoprecipitation experiments with APP in HEK293T cells (raw data not shown, Fig. 
3.2B-C showing three selective Mint2 ASD mutants).  Based on the co-
immunoprecipitation experiments with APP, I found that Mint2 R4Q, Mint2 T660M, and 
Mint2 N723S have the most dramatic and consistent changes compared to Mint2 wild 
type.  The data revealed that while Mint2 T660M increases interaction with APP, Mint2 
R4Q and Mint2 N723S decrease interaction with APP (Fig. 3.2B-C).   
Since Mint2 interacts with neurexin I, I also screened all Mint2 mutations in GST 
pull down experiments with neurexin I (raw data not shown, Fig. 4.1A showing GFP-
Mint2 N723S mutant).  In addition, I have screened some of these mutants in a 
membrane fractionation assay to determine whether they alter neurexin membrane 
localization.  The data revealed that Mint2 R4Q, Mint2 N723S, and Mint2 T660M all 
decreased the neurexin membrane localization compared to the wild type (Fig. 3.2D-E), 
suggesting that these mutations may be involved in neurexin membrane trafficking.  
As a secondary screening in neurons, the effects of three mutants (Mint2 R4Q, 
Mint2 T660M, and Mint2 N723S) were also examined in both dendritic development 
with Sholl analysis (Fig. 3.3) and electrophysiological analysis (Fig 3.4).  Both 
experiments indicated that Mint2 N723S mutant had the most pronounced phenotype 
compared to other mutants.   
Based on these extensive experiments described above, Mint2 N723S mutation 
was selected for my study because of the following reasons:  1) Mint2 N723S is located 
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on the PDZ domain, which interacts directly with neurexin I (Biederer et al. 2002), a 
highly implicated protein in autism.  However, the GST pull down assay indicates that 
Mint2 N723S does not alter neurexin interaction; 2) Mint2 N723S alters neurexin 
membrane localization in HEK293T cells, suggesting that Mint2 could be involved in 
neurexin trafficking and Mint2 N723S alters this function; 3) Mint2 N723S had the most 
dramatic phenotype in the Sholl analysis of dendritic growth compared to other mutants 
(Mint2 R4Q and Mint2 T660M); 4) Mint2 N723S had the most dramatic phenotype in 
electrophysiological analysis compared to other mutants (Mint2 R4Q and Mint2 T660M).  
 
Mint2 N723S mutant alters axon length and dendritic branching 
ASDs are associated with structural and functional abnormalities in neurons.  To 
determine whether Mint2 N723S leads to impairments in neuronal development which 
are often associated with ASD phenotypes, I examined axonal and dendritic growth in 
primary neurons.  Because Mints 1-3 have redundant functions and to examine the direct 
effects of Mint2 N723S mutant in neurons, I used a conditional knockout mouse line that 
is homozygous for Mint1 and 3 knockout and conditional floxed knockout for Mint2 
(Mint1-/-; fMint2//fMint2; Mint3-/-).  Primary hippocampal neurons from Mint1-/-; 
fMint2//fMint2; Mint3-/- newborn mice were cultured and I compared neurons that were 
co-infected at the day of plating with lentiviruses carrying cre and GFP-tagged Mint2 
wild type, Mint2 N723S, Mint2 ΔPDZ or heterozygous Mint2 N723S mutation referred 
to as +/N723S.  I wanted to determine whether Mint2 N723S alters the function of the 
PDZ domain, therefore, I used Mint2 ΔPDZ mutant was used as a negative control.  As 
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analyzed by immunoblotting, I found that primary neurons infected with the various 
lentiviruses expressing GFP-tagged Mint2 variants showed similar protein expression 
levels compared to endogenous Mint2 levels (Fig. 3.5A).  
To test whether the Mint2 N723S mutation alters axon polarization, I compared 
primary hippocampal neurons infected at 1 DIV with Mint2 wild type, Mint2 N723S, 
Mint2 ΔPDZ or +/N723S expressing lentivirus in Mint knockout neurons and 
immunolabeled at 3 DIV with SMI-312, a pan-axonal neurofilament marker.  The 
quantitative analysis showed Mint knockout neurons decreased axon length compared 
with Mint2 wild type-infected neurons.  By comparing Mint2 mutants with Mint2 wild 
type-infected neurons, neurons infected with Mint2 N723S, Mint2 ΔPDZ and +/N723S 
caused a decrease in the total axon length.  Mint2 ΔPDZ mutant shown a similar 
decreased in axon length compared to the Mint2 KO, suggesting that the PDZ domains 
are involved in axon development.  These results suggest that Mint2 has an important 
role in axon growth and the Mint2 N723S mutation leads to loss-of-function axonal 
impairments (Fig. 3.6A).   
  To determine whether Mint2 N723S leads to impairment of dendrite 
development, I infected M1-/-; fM2/fM2; M3-/- hippocampal neurons at the day of plating 
with lentiviral cre recombinase alone, or cre recombinase with Mint2 wild type or 
N723S, and immunostained with a dendritic marker, MAP2, at 5 DIV.  Sholl analysis 
was used to examine the complexity of the dendritic arbor and the overall pattern of 
arborization.  The results revealed that Mint knockout neurons and the N723S mutant 
shifted the distribution to the left compared to Mint2 wild type infected neurons (Fig. 
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3.7A), indicating that Mint2 is involved in dendrite development and N723S mutant 
decreases dendritic branching.  
 
Mint2 CNV promotes axon growth and dendritic branching 
  To determine whether Mint2 CNV leads to impairments in neuronal development, 
I characterized axon length and dendritic branching in wild type neurons in relation to 
different levels of Mint2 expression.  Hippocampal neurons were infected with control 
(ΔCre) or Mint2 wild type lentivirus at the day of plating and immunostained with 
antibodies against an axonal marker (SMI-312) at 3 DIV or a dendritic marker (MAP2) at 
5 DIV.  The neuronal culture was infected with an increasing dosage of Mint2 wild type 
lentivirus, which correlates with increasing Mint2 protein levels on the immunoblot 
(ranging from 0 to 3 fold of protein level) (Fig. 3.5B).  I found that Mint2 overexpression 
increased axon length compared to control (Fig. 3.6B).  In addition, Sholl analysis 
revealed that Mint2 overexpression shifted the distribution to the right compared to Mint2 
wild type infected neurons, indicating that Mint2 overexpression increased the total 
number of MAP2 positive processes (Fig. 3.7B).  Altogether, these results suggest that 
overexpression of Mint2 is involved in both axon and dendrite development and Mint2 
copy number variant promotes increased neuronal growth and is phenotypically similar to 
some patients with ASD.  
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Discussion 
  In the present study, I have showed the Mint2 ASD variants do not change Mint2 
expression (Fig. 1C).  This is not surprising, as most single-nucleotide polymorphisms 
(SNPs) do not change protein expression unless the point mutation encodes for a stop 
codon that leads to a premature stop in translation or for a key residue involved in protein 
folding.  However, functional deficit may still occur without expression change.  Since 
Mint2 is a multidomain adaptor protein, a mutation within a domain may interfere with 
Mint interacting with other proteins and therefore alter its function. 
Based on the published study, it is not known whether Mint2 N723S is 
transmitted paternally or maternally because the parental information is not available in 
the database.  Based on the NCBI SNP database, Mint2 N723S is not a common SNP.  
Therefore, I concluded that since Mint2 N723S is a rare point mutation in the study and 
in the general population, the individual is most likely to be heterozygous for the 
mutation.  Therefore, to mimic the physiological condition of the patient, I also examined 
the effect of Mint2 N723S heterozygosity on neuronal development and function.  
However, the overarching goal of my project is to determine the function of Mint2 in 
neuronal development and autism, not necessarily the effect of one rare point mutation.   
Mint2 is expressed earlier during gestation compared to Mint1 in mice (Ho et al. 
2003), suggesting that Mint2 must have a temporal specific function in brain 
development.  Mint2 copy number and sequence variants are associated with autism 
(Babatz et al. 2009), but its involvement in neurodevelopment is not known.  In this 
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chapter, I examined whether Mint2 copy number and sequence variant N723S alter 
neurodevelopment.   
Autistic individuals often have large brain size and too many synapses with a lack 
of synaptic pruning.  Therefore, I first determined whether Mint2 copy number variant 
contributes to neuronal overgrowth.  Copy number variant can either be gene deletion 
(leads to less protein production) or gene duplication (leads to more protein production).  
In this study, I only examined the effect of Mint2 copy number variant in term of gene 
duplication, by overexpression of Mint2 protein.  I examined the role of Mint2 
overexpression in axon growth and dendritic branching.  The data revealed that Mint2 
copy number variant increases axon length (Fig. 3.6B) and dendritic branching (Fig. 
3.7B), suggesting that Mint2 overexpression promotes overall neuronal growth that can 
contribute to the physical changes of the brain that are associated with autism.  More 
dendritic growth indicates more synapse formation during development, which correlates 
with the increase in frequency and amplitude in spontaneous excitatory 
neurotransmission (Sullivan et al. 2014).   
Mint2 is well studied in the literature for its presynaptic function (Biederer et al. 
2002, Ho et al. 2008).  The Sholl analysis of dendritic growth suggests that Mint2 
overexpression also has a postsynaptic function.  However, a Mint2 dendritic function is 
not completely novel.  Another study has found that Mint2 is involved in the dynamic of 
spine remodeling and Mint2 overexpression increases spine density (Jones et al. 2014).  
The increased in spine density suggests more synapse formation, which correlates well 
with the increases in dendritic branching I found in the Sholl analysis (Fig. 3.7B).   
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  I also examined the effects of Mint2 N723S on axon and dendrite development.  
The data revealed that Mint2 N723S decreases axon length (Fig. 3.6A) and dendritic 
branching (Fig. 3.7A) similar to the Mint2 knockout, suggesting that Mint2 N723S 
decreases overall neuronal growth and alters neuronal development.  To determine the 
precise domains that are involved, the PDZ domains deletion mutant was used as a 
control.  The rationale was that if domains other than the PDZ were involved, there 
would be little or no change in axon development compared to the Mint2 knockout 
neurons.  If the PDZ domains were involved in axon development, there would be a 
similar reduction in axon length as compared to the Mint2 knockout neurons.  The result 
revealed that Mint2 ΔPDZ mutant reduces the axon length similar to the Mint2 knockout 
neurons (Fig. 3.6A).  These results suggest the following: 1) Mint2 is involved in early 
neurodevelopment; 2) Mint2 N723S decreases axon development; and 3) PDZ domains 
are involved in the development of axon; 4) Mint2 N723S most likely alters the function 
of the PDZ domains; 5) It is interesting to note that Mint2 copy number variant (gain-of-
function mutation) and Mint2 sequence variant N723S (loss-of-function mutation) have 
opposite phenotypes in axonal and dendritic development.  
In summary, the effects of Mint2 overexpression and Mint2 knockout in axonal 
and dendrite growth clear indicate that Mint2 is involved in neuronal development, which 
is a novel finding.  This also indicated that Mint2 has both presynaptic (i.e. axonal) and 
postsynaptic effects (i.e. dendritic).  This is not fully surprising.  Previously, Mint2 has 
shown to display polarized localization in somatodendrites and axons, and it assumes 
different functions depending on its localization (Nakajima et al. 2001).  I speculate that 
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Mint2 copy number variant as a gain-of-function mutation and Mint2 N723S as a loss-of-
function mutation.  As of now, the precise mechanism of Mint2 in neuronal development 
is not known; however, since Mint2 is a neuronal adaptor protein, it may very likely 
traffic other proteins that are involved in axonal and dendritic growth.   
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Figure 3.1: Mint2 ASD mutants do not disrupt Mint2 expression in HEK293T cells.  
A, The locations of nonsynonymous variants for Mint2 in ASD and control subjects.  Human 
Mint2 mutants examined in this study include 7 unique ASD variants (above, red) and 4 control 
variants (below, black).  The *A632T mutation represents one autistic proband and one control.  
Figure adapted from Babatz, 2009.  B, Representative immunoblots of Mint2 protein levels in the 
cell lysate of HEK293T cells transfected individually with GFP-tagged Mint2 wild type or 
mutants. 
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Figure 3.2: Characterization of Mint2 mutants in HEK293T cells.   
A, Representative immunoblots of protein levels in the cell lysate of HEK293T cells.  APP was 
transfected together with GFP-tagged Mint2 wild type or Mint2 mutants. Mint2 proteins were 
probed with rabbit anti-GFP antibody.  APP proteins were probed with rabbit anti-APP antibody.  
GAPDH was used as a loading control on the same blot.  B-C, Co-immunoprecipation experiment 
demonstrating that Mint2 mutants alter binding of Mint2 to APP in transfected HEK293T cells.  
APP was transfected together with GFP-tagged Mint2 wild type, Mint2 R4Q, Mint2 T660M, or 
Mint2 N723S mutant in HEK293T cells.  Cell lysates were immunoprecipated with a rabbit anti-
GFP antibody and immunoblotted with a rabbit anti-APP antibody.  D-E, Membrane and 
cytosolic fractions of cell lysates from HEK293T cells transfected with neurexin Iα and GFP-
tagged Mint2 wild type, Mint2 R4Q, Mint2 T660M, or Mint2 N723S mutant.   
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Figure 3.3: Characterization of selective ASD Mint2 mutants in dendritic development.  
Mint2 N723S mutant decreases dendritic branching compared to Mint2 wild type.  
A-D, Mint2 N723S mutation decreases dendritic branching. Primary hippocampal neurons were 
infected with lentiviral cre recombinase alone (KO), lentiviral cre recombinase with Mint2 wild 
type (WT), Mint2 T660M, or Mint2 N723S mutant at the day of plating.  Cells were stained with 
MAP2 (a dendritic marker) at 5 DIV.  Sholl analysis based on the number of dendritic crossings 
distributed over the distance from the cell body in pixels (n=25-30 neurons for each group). * 
p<0.05.  Scale bars, 20 µm.  
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Figure 3.4: Characterization of selective Mint2 ASD mutants in neurotransmission.  Mint2 
N723S mutant decreases excitatory spontaneous neurotransmitter release in wild type 
neurons.   
Bar graphs showing that Mint2 N723S had the most dramatic decreased in the frequency of 
mEPSC compared to the control (Mint2 wild type) and other Mint2 mutants (Mint2 R4Q and 
Mint2 T660M).  The amplitude of mEPSC was not changed between all treatments.   
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Figure 3.5: Protein expression levels of Mint2 wild type or mutations in lentivirus-infected 
neuron.   
A, Representative immunoblot of Mint2 protein levels from cell lysates of M1-/-; fM2/fM2; M3-/- 
neurons infected with Δcre (control for cre recombinase), cre recombinase alone, cre recombinase 
with and GFP-Mint2, N723S, ΔPDZ, or Mint2+/N723S (heterozygous mutant).  To probe for the 
Mint2 protein, rabbit anti-Mint2 antibody was used here.  B, Representative immunoblot of Mint2 
protein levels from cell lysates of wild type neurons infected with increasing dosage of Mint2 
wild type lentivirus, which correlates with increasing Mint2 protein levels on the immunoblot 
(ranging from 0 to 3 fold protein level increase).  To probe for the Mint2 protein, rabbit anti-
Mitn2 antibody was used here.  GAPDH was used as a loading control on the same blot. 
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Figure 3.6: Mint2 sequence variant N723S and copy number variant alter axon 
development.   
A, Mint2 N723S mutation decreases axon growth.  Representative images of primary 
hippocampal neurons at 3 DIV infected with lentiviral cre recombinase together with with Mint2 
wild type (WT), cre recombinase alone (KO), cre recombinase together with Mint2 N723S, Mint2 
ΔPDZ, or heterozygous (Mint2+/N723S) mutant on the day of plating.  Cells were stained with an 
axonal marker, SMI-312.  Numbers in bars represent analyzed cells from 2 independent neuronal 
cultures (WT, n=34; KO, n=75; N723S, n=79; ΔPDZ, n=38; +/N723S, n=60).  B, Mint2 CNV 
increases axon growth.  Representative images of primary hippocampal neurons at 3 DIV infected 
with lentirivral control or Mint2 wild type and stained with SMI-312 (axonal marker) at 2 DIV.  
Numbers in bars represent analyzed cells from 3 independent neuronal cultures (control, n=85, 
Mint2 OE=75).  Scale bars, 20 µm.  *p<0.05; **p<0.01; ***p<0.005.  
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Figure 3.7: Mint2 sequence variant N723S and copy number variant alter dendrite 
development.   
A, Mint2 N723S mutation decreases dendritic branching.  Representative images of Mint-
deficient hippocampal neurons (Mint knockout background) infected with lentiviral cre 
recombinase alone (KO), cre recombinase together with Mint2 wild type or Mint2 N723S mutant 
on the day of plating.  Cells were stained with MAP2 (a dendritic marker) at 2-3 DIV.  Sholl 
analysis showed the number of dendritic crossings distributed over the distance from the cell 
body in pixels (n = 30 neurons for each group).  B, Mint2 CNV increases dendritic growth and 
branching.  Representative images of wild type hippocampal neurons (wild type background) 
infected with lentiviral control (wild type) or Mint2 wild type (Mint2 OE) on the day of plating.  
Cells were stained with MAP2 at 3-5 DIV.  Sholl analysis showed the number of dendritic 
crossings distributed over the distance from the cell body in pixels (n = 20-30 neurons for each 
group).  *p<0.05.  Scale bars, 20 µm. 
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CHAPTER FOUR: Mint2 N723S alters neurexin localization and trafficking 
 
Introduction 
Mint2 is a multidomain protein and its PDZ domains interact directly with 
neurexin I (Biederer, 2002), a neuronal cell adhesion protein that is highly implicated in 
autism.  Neurexin is involved in numerous synaptic functions such as synapse formation 
and synaptic transmission.  The proper membrane targeting of neurexin is important for 
its synaptic function.  Neurexin membrane trafficking depends on its C-terminal PDZ-
binding motif (Fairless et al. 2008), which interacts with PDZ-domain proteins, such as 
CASK and Mints.  Previously, a study found that PDZ domains of Mint1 are involved in 
NMDA receptor subunit trafficking to the postsynaptic membrane (Setou et al. 2000).  I 
hypothesize that Mint2 is involved in neurexin membrane trafficking, possibly via its 
PDZ domains.  To test this hypothesis, I examined the role of Mint2 for neurexin 
membrane localization in HEK293T cells and synapse targeting in neurons.  
Because the multi-domain structure and the nature of their interacting partners 
determine the function of Mint proteins, this raises the question whether Mint2 mutants 
alter the binding to any of its interacting partners and affect Mint2 function.  I therefore 
analyzed the N723S mutation that targets a conserved asparagine residue in the second 
PDZ domain of Mint2 because the PDZ domains of Mint2 binds to Nrxn1α, a strong 
candidate gene for ASD. 
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Results 
Mint2 N723S does not disrupt its binding to neurexin in HEK293T cells 
Mints are multi-domain proteins and bind to several synaptic (Munc18-1, CASK, 
neurexin I, and Ca2+ channels) and Alzheimer’s disease (AD)-related proteins (APP, 
presenilin 1) – see Fig. 3.1A.  This raises the question of whether Mint2 mutants alter the 
binding to any of its interacting partners and affect Mint2 function.  I therefore analyzed 
the effect of a single amino-acid substitution (N723S) that targets a conserved asparagine 
residue in the second PDZ domain of Mint2, because the PDZ domains of Mint2 bind 
directly to neurexin I, a strong candidate gene in autism (Südhof 2008).  To determine 
whether the Mint2 N723S mutation alters its binding to neurexin I, I used the isolated 
cytoplasmic tail of neurexin I, immobilized as a bacterially expressed GST-fusion protein 
and tested whether neurexin I could pull down full-length Mint2 wild type, Mint2 N723S, 
or Mint2 ΔPDZ (PDZ domains deletion mutant) that were produced in transfected 
HEK293T cells. Consistent with previous studies, Mint2 wild type binds to Nrxn Iα 
whereas C-terminal truncation of the two PDZ domains of Mint2 (Mint2 ΔPDZ) 
dramatically reduced its binding to Nrxn Iα	  (Biederer and Südhof 2000).  Meanwhile, the 
Mint2 N723S mutation did not disrupt Nrxn1α binding. 
 
Mint2 N723S decreases neurexin membrane localization in HEK293T cells 
Since Mints are involved in membrane protein trafficking to the cell surface 
(Chaufty et al. 2012, Matos et al. 2012, Sullivan et al. 2014), I examined whether Mint2 
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is involved in neurexin I trafficking and affects neurexin membrane localization.  I co-
transfected neurexin Iα together with GFP control, GFP-Mint2 wild type, GFP-Mint2 
N723S, or GFP-Mint2 ΔPDZ in HEK293T cells.  The proteins in the membrane and 
soluble fraction were separated by ultracentrifugation.  In the membrane fraction, I found 
that Mint2 wild type significantly increases neurexin I compared to the GFP control, 
suggesting that Mint2 traffics neurexin to the membrane (Fig. 4.1B).  In contrast, both 
Mint2 N723S and Mint2 ΔPDZ mutants decreased the membrane fraction of neurexin Iα 
compared to Mint2 wild type (Fig. 4.1B). Interestingly, I detected low cytosolic neurexin 
levels in Mint2 ΔPDZ mutant suggesting the ΔPDZ mutant may be sequestering neurexin 
to a non-functional, cytosolic compartment.  Combined, these results indicate (1) Mint2 
binds and traffics neurexin to the membrane, (2) Mint2 N723S mutant binds neurexin 
effectively, but it can’t traffic neurexin to the membrane efficiently, and (3) Mint2 ΔPDZ 
mutant binds and traffics neurexin less efficiently.   
To further validate Mint2-mediated neurexin Iα membrane localization, I 
visualized and quantified the membrane neurexin level by immunocytochemistry.  I co-
transfected mCherry-neurexin Iα together with GFP control, GFP-Mint2 wild type, GFP-
Mint2 N723S, or GFP-Mint2 ΔPDZ in HEK293T cells.  24 hours post-transfection, cells 
were fixed without being permeabilized to allow the visualization of plasma membrane 
neurexins only.  Cells were labeled with rabbit anti-mCherry antibody to amplify the 
mCherry signal.  Similar to the result I found in cellular fractionation (Fig. 4.1B), I found 
that both Mint2 N723S and Mint2 ΔPDZ mutants decrease membrane neurexin levels 
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compared to the wild type, suggesting that Mint2 N723S alters neurexin membrane 
trafficking (Fig. 4.1C).  
 
Mint2 N723S decreases neurexin protein stability in HEK293T cells 
Membrane proteins that are not correctly targeted to their proper location will 
eventually be degraded.  To determine whether Mint2 is involved in neurexin I protein 
stability in the total cell lysate, I co-transfected neurexin Iα together with GFP control, 
GFP-Mint2 wild type, GFP-Mint2 N723S or GPF-Mint2 ΔPDZ in HEK293T cells.  Total 
cell lysates were harvested and immunoblotted for neurexin Iα.  The results revealed that 
Mint2 wild type increases neurexin I protein level compared to GFP control, suggesting 
that Mint2 stabilizes neurexin I protein expression in the total cell lysate (Fig. 4.2A).  
Also, Mint2 N723S decreases neurexin I protein level compared to Mint2 wild type, 
suggesting that the mutation destabilizes neurexin I (Fig. 4.2A).  Accordingly, co-
expression of neurexin with GFP-Mint2 ΔPDZ, which affects neurexin binding, 
decreased neurexin levels, suggesting the Mint2 binding to neurexin is critical for 
stability. 
Also, it is important to note that the neurexin banding patterns were altered.  The 
GFP control or Mint2 ΔPDZ mutant transfected cells have double banded neurexin Iα.  In 
contrast, Mint2 wild type or Mint2 N723S transfected cells have single banded neurexin 
Iα, suggesting that there are multiple forms of neurexins.  Mint2 wild type co-expression 
increased the levels and altered the migration of neurexin.  Specifically, Mint2 wild type 
doubled Nrxn1α levels and transformed the two immature bands of ~160 and ~190 kDa 
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bands to one mature band.  Together, these results suggest that not only Mint2 is involved 
in neurexin Iα membrane localization, but it is also involved in its maturation and 
processing in the Golgi.   
 
Mint2 is enriched in the Golgi apparatus in wild type hippocampal neurons 
 
Since Mint2 is a neuronal-specific protein, I next examined Mint2 localization in 
neurons.  Mint-deficient hippocampal neurons were infected with Mint2 wild type, Mint2 
N723S, or Mint2 ΔPDZ lentivirus at 3 DIV and immunostained for GM130 (a cis-Golgi 
marker).  Although Mint2 is well established in the literature for its function at the 
synapse, I did not observe an obvious enrichment of Mint2 at synapses (data not shown).  
However, I found that Mint2 wild type is enriched in the Golgi (Fig. 4.3), confirming a 
previous finding (Biederer et al. 2002).  There was no obvious difference between Mint2 
wild type and Mint2 N723S in Golgi localization.  However, I found that Mint2 ΔPDZ 
completely lost its Golgi localization compared to the wild type, suggesting that PDZ 
domains are essential for Mint2 Golgi localization.  It is possible that Mint2 binds to a 
membrane protein in the Golgi, possibly via the PDZ domains.  
 
Mint2 is enriched in the Golgi apparatus in Mint-deficient hippocampal neurons 
In addition to the wild type hippocampal neurons, I also examined Mint2 Golgi 
localization in Mint-deficient neurons to see if the phenotype is reproducible in both 
neuron types.  Here, Mint-deficient (Mints 1-3 deficient) hippocampal neurons were 
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infected with lentiviral cre recombinase together with Mint2 wild type or Mint2 ΔPDZ 
lentivirus at 3 DIV and immunostained for the cis-Golgi marker, GM130.  Similar to 
what I found in the wild type neurons (Fig. 4.3), Mint2 wild type displayed a pronounced 
Golgi localization and Mint2 ΔPDZ completely lost its Golgi localization as compared to 
the wild type (Fig. 4.4).  
Interestingly, I also observed that Mint2 Golgi localization is neuronal specific 
(Fig. 4.4  — see asterisk).  Mint2 lentivirus also infects glial cells due to a non-neuronal 
specific promoter, ubiquitin.  However, Mint2 does not localize to the glial Golgi (Fig. 
4.4 —see arrow), further validating that Mint2 functions as a neuronal specific protein.  It 
is possible that glial cells do not express binding partners of Mint2 in the Golgi to 
facilitate the Golgi localization. 
 
Mint2 N723S decreases the kinetics and mobility at the Golgi and neuronal 
processes 
Previous studies have shown that Mints function at the Golgi to control polarized 
trafficking of axonal membrane proteins in Drosophila (Gross et al. 2013).  Since Mints 
are largely localized to Golgi (Fig. 4.3 and Fig. 4.4), I wanted to test the possibility that 
Mints are mobile proteins which control and traffic membrane proteins.  I first performed 
fluorescence recovery after photobleaching (FRAP) to determine the kinetics of Mint2 
protein in live primary mouse neurons that were infected with GFP-Mint2 wild type or 
GFP-Mint2 N723S.  I found that GFP-Mint2 fluorescence signal was effectively depleted 
by photobleaching and partially recovered in the Golgi as would be expected for a mobile 
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protein (Fig. 4.5A).  Indeed, 58% of GFP-Mint2 wild type recovered within 150 s, 
indicating that a large proportion of Mint2 wild type is mobile (Fig. 4.5B).  However, the 
fluorescence recovery pattern was different; 58% of GFP-Mint2 wild type recovered 
within 150s as compared with 45% of GFP-Mint2 N723S, suggesting that N723S is less 
mobile in the Golgi and/or its recruitment from the cytosol is less dynamic (Fig. 4.5C).  
The time at 50% of the recoverable fluorescence (τ1/2) from GFP-Mint2 wild type and 
N723S at the Golgi was not different suggesting Mint2 N723S did not alter puncta 
turnover and stability within the Golgi.  
To monitor the mobility of GFP-Mint2 puncta in neuronal processes, we used 
kymograph analysis to plot the fluorescence intensity of Mint2 wild type and N723S 
mutant.  Mobile and stationary puncta could be visualized with stationary puncta seen as 
vertical bands and mobile puncta are indicated by diagonal bands within the kymograph 
(Fig. 4.5E). Interestingly, while the speed of the mobile Mint2 puncta was similar in wild 
type and N723S mutant, the percentage of immobile Mint2 puncta was greater in the 
N723S mutant (Fig. 4.5F and G). Overall, these data demonstrate that Mint2 is a mobile 
protein in neurons capable of trafficking from the Golgi to the processes; however the 
N723S mutant leads to reduced mobility.  
 
Mint2 wild type co-localizes with neurexin Iα  in neuronal soma and axon 
Since Mint2 has a pronouned Golgi localization (Fig. 4.3 and 4.4), it would be 
interesting to determine whether neurexin Iα and Mint2 are co-localized in neurons, 
indicating that they may be trafficked together.  Wild type hippocampal neurons were 
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transfected with GFP-Mint2 wild type and pSyn5-E-mCherry-Neurexin Iα at 5 DIV and 
labeled with rabbit anti-mCherry at 7 DIV.  The data revealed that GFP-Mint2 wild type 
co-localizes with mCherry-Neurexin Iα in the soma next to the nucleus (Fig. 4.4).  In 
addition, I also found that GFP-Mint2 wild type puncta co-localizes with mCherry-
Neurexin Iα puncta in the axon, suggesting that Mint2 and neurexin Iα may traffic 
together in vesicles. 
 
Mint2 N723S alters neurexin Iα  axonal targeting to the synapse 
Previously, I found that Mint2 N723S decreases membrane neurexin Iα compared 
to Mint2 wild-type in HEK293T cells (Fig. 4.2B-C).  Here, I wanted to determine if this 
phenotype can be recapitulated in neurons.  I monitored Mint2-Nrxn1a colocalization at 
physiological synapses formed between neurons. Primary hippocampal neurons were co-
transfected with mCherry-tagged neurexin Iα  and GFP-control, GFP-Mint2 wild type or 
GFP-Mint2 N723S at 4-5 DIV.  Cultured neurons were fixed at 7 DIV, and I quantified 
colocalization by percentage of colabeled Nrxn Ia with GFP in axonal processes.  I 
counted the number of GFP-Mint2 wild-type puncta and mCherry-tagged neurexin Iα 
puncta individually for each axon.  Next, I counted how many of them are co-localized 
together.  I observed a prominent punctate GFP signal with Mint2 wild type colocalized 
perfectly with the expression of mcherry-NrxnIα (Fig. 4.7A and 4.7B).  The 
colocalization signal was not as robust when cultured neurons were transfected with 
GFP-Mint2 N723S. 
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To validate that the colocalization signal was synaptic, I performed an extensive 
immunofluorescence analysis using a presynaptic marker.  I co-transfected wild type 
mouse hippocampal neurons with mCherry-tagged neurexin Iα with GFP-Mint2 wild 
type or GFP-Mint2 N723S at 7 or 9 DIV.  Neurons were labeled with rabbit anit-mCherry 
polyclonal antibodies  (to enhance the visualization of the mCherry signal) and rabbit 
anti-synaptobrevin 2 (to visualize the presynaptic terminal).  The degree of co-
localization of mCherry-tagged Neurexin Iα and synaptobrevin 2 indicates the number of 
neurexin Iα vesicle trafficked to the presynaptic terminal.  The data revealed that Mint2 
wild type increases the number of neurexin Iα vesicle trafficked to the presynaptic 
membrane compared to EGFP control (Fig. 4.7C and 4.7D), suggesting that Mint2 in 
involved in neurexin Iα trafficking.  In addition, Mint2 N723S decreases numbers of 
neurexin Iα trafficked to the presynaptic membrane compared to Mint2 wild type, which 
is consistent with less neurexin Iα at axons (Fig. 4.7A and 4.7B).  
 
Discussion 
 
Autism is a neurodevelopment disorder with a strong genetic contribution.  
Among all the genes, disruption of neurexin I is highly implicated in autism (Kim et al. 
2008).  Neurexin I interacts directly with the PDZ domains of Mint2 (Biederer et al. 
2002).  However, it is not clear which PDZ domain directly interacts with neurexin.  To 
determine whether an altered interaction can disrupt neurexin function, I first examined 
Mint2-neurexin I interaction in HEK293T cells.  I did not find any binding deficit 
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between Mint2 N723S mutant and neurexin I compared to the wild type in GST pull 
down experiments (Fig. 4.1A).  However, I found that Mint2 N723S significantly 
decreases neurexin I membrane localization in HEK293T cells (Fig. 4.1B-C).  Moreover, 
Mint2 ΔPDZ mutant also decreased neurexin I membrane localization compared to Mint2 
wild type (Fig. 4.1B-C).  It is interesting to note that Mint2 ΔPDZ mutant binds neurexin 
less efficiently and therefore does not traffic neurexin properly.  In contrast, Mint2 
N723S binds to neurexin normally, but still alters neurexin I trafficking.  Therefore, 
Mint2 ΔPDZ and Mint2 N723S alter neurexin I membrane localization through two 
different mechanisms.  One possible explanation is that Mint2 N723S binds to neurexin, 
but it does not release neurexin to the membrane.  This explanation suggests that the 
cargo must be somehow mislocalized or degraded, confirming what I found in both 
HEK293T cells (Fig. 4.1 and 4.2) and neurons (Fig. 4.7).   
It is also interesting to note that neurexin Iα in the total cell lysate have different 
banding patterns (Fig. 4.2A).  The GFP control or GFP-Mint2 ΔPDZ mutant transfected 
cells have double-banded neurexins.  In contrast, GFP-Mint2 wild type or GFP-Mint2 
N723S transfected cells only display single-banded neurexins.  Together, these results 
indicate that there are two different species of neurexins, suggesting that different post-
translational modifications are involved.  A membrane protein such as neurexin I is first 
translated in the endoplasmic reticulum.  Posttranslational modification starts in the 
endoplasmic reticulum and continues in the Golgi.  Since Mint2 is a neuronal adaptor 
protein localized to the neuronal Golgi apparatus, it is possible that it shuttles its cargo 
between Golgi compartments for posttranslational modification.  Membrane proteins that 
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are not properly shuttled by Mint2 would not be properly modified and possibly mis-
localized.  Therefore, Mint2 may be involved in the posttranslational modification of 
neurexin. 
A function of Mint2 in protein trafficking is not surprising.  In vertebrate neurons 
(Biederer et al. 2002) and C. elegans, Mint 1 is concentrated at the Golgi apparatus and 
localized throughout axons and dendrites, strongly suggesting that Mint1 is involved in 
protein trafficking.  The PDZ domains of Mint1 have been shown to traffic NMDA 
receptor subunits to the postsynaptic membrane by binding to Kif17, a kinesin motor 
protein (Setou et al. 2000). Similar to Mint1, Mint2 also has a pronounced Golgi 
localization (Fig. 4.3 and 4.4). Since Mints 1 and 2 are highly conserved at the C-
terminus, Mint2 could, in principle, interact with Kif17 or other kinesin proteins to traffic 
neurexin I to the membrane.  The trafficking complex between Mint2 and neurexin 
involves other motor proteins or adaptors.  It would be interesting to identify the players 
in the trafficking complex, as it could reveal novel interactions.   
Previously, Mint2 has been shown to be concentrated in the trans-Golgi complex 
with TGN38 (a trans-Golgi marker) labeling in cultured hippocampal neurons doubled 
stained with antibodies against endogenous Mint2 and trans-Golgi (Biederer et al. 2002).  
I found that Mint2 is also located in the cis-Golgi complex with GM130 (a cis-Golgi 
marker) labeling in cultured hippocampal neurons infected with GFP-Mint2 wild type 
and labeled with antibody against endogenous cis-Golgi (Fig. 4.3 and 4.4).  Trans-Golgi 
localization indicates the involvement in membrane transport because it is physically 
closer to the cell membrane.  However, the functional role of the cis-Golgi localization of 
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Mint2 is not clear.  Mint2 could shuttle membrane proteins from the cis-Golgi to trans-
Golgi or from the ER to the cis-Golgi.  However, since Mint2 is not localized in the ER, 
the ER to the cis-Golgi shuttling is unlikely.  Also, Mint2 may carry out specialized 
functions in different Golgi compartments.  
Mint2 Golgi localization is not a novel finding.  What is really interesting is that 
Mint2 Golgi localization is PDZ domain dependent, which is a novel finding.  The PDZ 
domains are involved in Mint2 Golgi localization in both wild-type neurons (Fig. 4.3) 
and Mint-deficient neurons (Fig. 4.4), strongly suggesting that the PDZ domains target 
Mint2 to the Golgi.  A plausible mechanism is that the PDZ domains bind to other 
proteins and recruit Mint2 to the Golgi.  It is important to note that Mint2 Golgi 
localization is not visible in HEK293T cells if Mint2 was transfected alone (Fig. A1.2), 
suggesting that other proteins (e.g., neuronal specific adaptor proteins) are involved in 
Mint2 Golgi targeting that are only present in neurons.   
In neurons, Mint2 N723S decreases neurexin I localization in axons (Fig. 4.7A-B) 
and presynaptic terminals (Fig. 4.7C-D) compared to Mint2 wild type.  Mint2 N723S also 
showed a decrease in FRAP of Golgi compared to Mint2 wild type (Fig. 4.5).  Together, 
these data suggest that Mint2 N723S is more trapped in the Golgi and therefore not able 
to move neurexin to presynaptic terminals efficiently.  
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Figure 4.1: Mint2 N723S decreases neurexin Iα  membrane trafficking in HEK293T cells.  
A, Pull down experiment of HEK293T cells transfected with Mint2 wild type or Mint2 N723S 
mutation on immobilized GST-neurexin I (Nrxn I) fusion protein.  Coomassie stained gel of 
GST-Nrxn I.  B, Quantification of Mint2 wild type or mutants pulled down by GST-neurexin I.  
C, Mint2 N723S decreases neurexin I trafficking to the membrane.  HEK293T cells co-
transfected with neurexin Iα (Nrxn Iα) together with GFP control, GFP-Mint2 wild type (WT), 
GFP-Mint2 N723S or GFP-Mint2 ΔPDZ were subjected to membrane and cytosolic fractionation 
and blotted with antibody against Nrxn I and Mint2.  Na+/K+ ATPase and GAPDH were used as a 
membrane and cytosolic marker, respectively.  D, Quantification of the effect of Mint2 N723S 
mutant on Nrxn Iα membrane protein level.  E, Representative images of HEK293T cells 
transfected with mCherry-Neurexin Iα together with  EGFP control, GFP-Mint2 wild type, GFP-
Mint2 N723S, or GFP-Mint2 ΔPDZ.  Cell surface mCherry-Neurexin Iα signal was amplified 
with rabbit anti-mCherry antibody without detegent permeabilization.  F, Quantification of the 
effect of Mint2 mutants on cell surface mCherry-Neurexin Iα.  *p<0.05; **p<0.010; ***p<0.005. 
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Figure 4.2: Mint2 N723S decreases neurexin Iα  protein stability in HEK293T cells.  
 A, HEK293T cells were co-transfected with neurexin Iα (Nrxn Iα) together with GFP control, 
Mint2 wild type, Mint2 N723S, or Mint2 ΔPDZ mutant.  Total cell lysates were harvested and 
immoblotted with antibodies against Nrxn I, Mint2, and GAPDH.  GAPDH was used a loading 
control in the same blot.  B, Effect of Mint2 mutants on Nrxn Iα total protein expression.  
*p<0.05; **p<0.010; ***p<0.005.  
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Figure 4.3: Mint2 Golgi localization in wild type hippocampal neurons is PDZ domain 
dependent. 
Representative images of wild-type hippocampal neurons infected with GFP-Mint2 wild type 
(WT), GFP-Mint2 N723S, or GFP-Mint2 ΔPDZ.  Neurons were stained with GM130 (a Golgi 
maker) at 14 DIV.  Both Mint2 WT and N723S co-localize with Golgi.  The lower panel shows 
that Mint2 ΔPDZ mutant loss its Golgi localization. 
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Figure 4.4: Mint2 Golgi localization in Mint-deficient hippocampal neurons depends on the 
PDZ domains.  
Representative images of Mint-deficient hippocampal neurons infected with GFP-Mint2 wild 
type (WT) or GFP-Mint2 ΔPDZ lentivirus were labeled with GM130 (a cis-Golgi marker) at 14 
DIV.  The upper panel shows that Mint2 WT (green) co-localizes with Golgi (red).  The asterisk 
indicates a neuron with Golgi localization.  The arrow shows that a glial cell without Golgi 
localization, suggesting that Mint2 Golgi localization in neuronal-specific.  The lower panel 
shows that Mint2 ΔPDZ mutant does not localized to the Golgi, suggesting that PDZ domains are 
required for Mint2 Golgi localization.  Note that due to usage of GFP-tagged cre recombinase 
lentivirus in Mint-deficient hippocampal neurons, the nuclei shown here are in color green. 
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Figure 4.5: Mint2 N723S is less mobile in Golgi in wild type hippocampal neurons. 
A, FRAP imaging of GFP-Mint2 wild type and N723S in the Golgi.  Regions encompassing 
Golgi were photobleached using 3 passes (15 s total) of 100% laser power, which reduced the 
initial fluorescence intensity to 25%.  Recovery fluorescence was acquired with 1% laser power 
and imaged every 5 s for 150 s.  B, Normalized intensity of GFP-Mint2 wild type and N723S 
signal during fluorescence recovery after photobleaching.  C, Bar graph shows the percentage of 
Mint2 wild type or N723S that is mobile in the Golgi.  *p<0.05; **p<0.010; ***p<0.005. 
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Figure 4.6: Mint2 wild type co-localizes with Neurexin Iα  in neuronal soma and axon.  
Representative images of wild type hippocampal neurons transfected with GFP-Mint2 wild type 
(WT) and mCherry-Neurexin Iα at 5 DIV.  Neurons were stained with rabbit anti-mCherry (to 
visualize and amplify the mCherry signal) at 7 DIV.  GFP-Mint2 WT (green) co-localizes with 
mCherry-Neurexin Iα (red) and the merge images are displayed in yellow.   
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Figure 4.7: Mint2 N723S decreases Neurexin Iα  axonal targeting to the synapse.  
A, Representative images of axonal segments of wild type hippocampal neurons transfected with 
mCherry-Neurexin Iα together with  EGFP control, GFP-Mint2 wild type or GFP-Mint2 N723S 
at 5 DIV.  Neurons were labeled with rabbit anti-mCherry antibody at 7 DIV.  B, Quantification 
of mCherry-Neurexin Iα and GFP colocaliztion.  Data are means ± SEM.  Differences were 
determined by one-way ANOVA.  Cells were collected from a total 30 axons from 3 independent 
cultures.  Scale bars, 5 µm.  C, Representative images of wild type hippocamapl neurons 
transfected with mCherry-Neurexin Iα together with EGFP control, GFP-Mint2 wild type or 
GFP-Mint2 N723S at 7 DIV and immunostained for mouse anti-synaptobrevin at 9 DIV.  
Numbers in bars represent analyzed axons from 3 neuronal cultures (EGFP=14 cells, WT=38 
cells, N723S=32 cells).  D, Quantification of mCherry-Neurexin Iα and synaptobrevin (Syb) 
colocaliztion.  Data are means ± SEM.  Differences were determined by one-way ANOVA.  
Numbers in bars represent analyzed neuronal processes from 1 neuronal culture (EGFP=23 
processes, WT=16 processes, N723S=21 processes).  Scale bars, 10 µm. *p<0.05; **p<0.010; 
***p<0.005. 
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CHAPTER FIVE: Mint2 N723S and CNV alter excitatory synaptogenesis and 
synaptic transmission 
 
Introduction 
The human brain has billions of neurons and each neuron is capable of generating 
1,000 to 10,000 synapses.  Synapses are specialized asymmetric intercellular contacts 
between neurons that function in neurotransmission.  During neurotransmission, 
neurotransmitters are released from the presynaptic terminal into the synaptic cleft and 
bind to the receptors on the postsynaptic membrane.  In order for the brain to function 
properly, signals from neuron to neuron must be carried out with both spatial and 
temporal precision.   
Our laboratory has shown that Mint2 overexpression contributes to synaptic 
dysfunction (Sullivan et al. 2014).  Mint2 overexpression in wild type neurons increases 
miniature event frequency and amplitude in excitatory synapses compared to control 
neurons, suggesting that Mint2 overexpression alters quantal size, quantal frequency, 
synapse number, and/or postsynaptic receptor numbers.  Moreover, acute knockout of all 
three Mints in cultured neurons decreases spontaneous neurotransmitter release at 
excitatory synapses, which can be rescued with Mint2 wild type (Ho et al. 2006, Sullivan 
et al. 2014).  Together, these data strongly suggest that Mint2 is involved in spontaneous 
excitatory neurotransmission.  
Synaptogenesis, the generation and maturation of synapses, is mediated by cell 
adhesion proteins, neurexins and neuroligins (Serafini 1999, Yamagata et al. 2003).  
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Synaptogenesis has two steps.  First, the initial contact between the axonal growth cone 
and a postsynaptic target must be established.  Second, the assembly of presynaptic and 
postsynaptic proteins at the contact site leads to the maturation and specification of the 
synapse.  
In the previous chapter, I found that Mint2 N723S alters neurexin I membrane 
localization in HEK293T cells (Fig. 4.1B-C).  In neurons, Mint2 N723S also decreases 
neurexin I axonal targeting to the synapses (Fig. 4.7).  Based on these findings, I 
hypothesized that Mints N723S would lead to decreased synapse formation.  In this 
chapter, I examined the effect of Mint2 N723S in synapse formation by performing 
heterologous synapse formation assay.  In addition, I also examined the effect of Mint2 
N723S on spontaneous excitatory neurotransmission to determine whether an altered 
synaptogenesis leads to an altered neurotransmission.  To correlate function to form, 
lastly, I examined synapse ultrastructure to determine whether Mint2 N723S caused any 
structural deficit of the synapse.  I also examined Mint2 copy number variant, with the 
exception that the electrophysiological analysis was previously published (Sullivan, 
2014).  
 
Results 
Mint2 N723S mutant decreases synaptogenesis 
To determine whether Mints are functional in synaptic formation dependent on 
neurexin-neuroligin (Nrxn-NL) binding, I used a neuron-fibroblast co-culture approach 
where it has been shown that NL-1 expressed in non-neuronal cells such as COS-7 cells 
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induces the formation of presynaptic specifications in contacting neuronal axons 
(Scheiffele et al. 2000).  I infected Mint-deficient hippocampal neurons with Mint2 wild 
type, Mint2 N723S, Mint2 ΔPDZ, or heterozygote (+/N723S) lentiviruses.  At DIV 10, I 
seeded COS-7 cells transfected with mVenus-NL-1 to induce synapse formation 
indicated by presynaptic synapsin staining that was clustered on NL-1 expressing COS-7 
cells.  I found that neurons lacking Mints (Mint KO) impaired synapse formation 
compared to wild type neurons (Fig. 5.1A), suggesting that Mint2 is involved in synapse 
formation.  Infection of lentiviral Mint2 wild type was able to rescue heterologous 
synapse formation in Mint-deficient neurons.  Also, I found that Mint2 N723S, ΔPDZ, or 
heterozygous +/N723S were not able to rescue the presynaptic clustering of synapsin in 
Mint-deficient neurons suggesting the N723S mutant may not efficiently transport 
neurexin to the presynaptic membrane to rescue heterologous synapse formation.  
Moreover, these results suggest that neurexin membrane transport requires the Mint2 
PDZ domains. 
 
Mint2 N723S mutant decreases spontaneous neurotransmitter release 
To determine whether the morphological changes in neuronal growth (Fig. 3.3A) 
and synapse numbers in Mint2 N723S (Fig. 5.1A) neurons lead to functional alterations 
in synaptic transmission, I examined the effect of the Mint2 N723S mutation on 
excitatory synaptic transmission by whole-cell voltage-clamp recordings to measure the 
frequency and amplitude of spontaneous miniature events from Mint-deficient (M1-/-; 
fM2/fM2; M3-/-) hippocampal neurons treated with lentiviral cre recombinase alone (KO), 
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cre recombinase and rescue with Mint2 wild type, Mint2 N723S, or Mint2 ΔPDZ 
lentivirus.  I found that consistent with the previous studies (Ho et al. 2006), Mint-
deficient neurons (Mint2 KO) showed a reduction in “mini” frequency in excitatory 
synapses compared to Mint2 wild type-infected neurons.  In addition, Mint2 N723S 
mutant caused a 46% decrease of “mini” frequency in excitatory synapses compared to 
Mint2 wild type, suggesting that N723S mutation decreases the frequency of quantal 
release or synapse density (Fig. 5.2A).  In addition, I found that Mint2 ΔPDZ and Mint2 
KO neurons showed a similar decrease in “mini” event frequency compared to the wild 
type (Fig. 5.2A), suggesting that PDZ domains are involved in neurotransmission in the 
presynaptic terminal.  However, “mini” amplitudes were not changed between all 
treatment groups (Fig. 5.2A), indicating that Mint2 mutations did not change the quantal 
size or postsynaptic receptor number. 
To further validate whether heterozygous Mint2 N723S alters spontaneous 
excitatory synaptic transmission, I used whole-cell voltage-clamp recordings to measure 
the frequency and amplitude of spontaneous miniature events from wild type 
hippocampal neurons treated with lentiviral Mint2 wild type or N723S mutant.  
Consistent with what I found in Mint-deficient neurons (Fig. 5.2A), there was a similar 
48% reduction of “mini” frequency and no change in “mini” amplitude with Mint2 
N723S as compared to the wild type, suggesting that Mint2 N723S could be a dominant 
negative mutation (Fig. 5.2B).  Overall, the results from both Mint knockout background 
(Fig. 5.2A) and wild type background (Fig. 5.2B) strongly indicate that Mint2 N723S 
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impairs spontaneous excitatory synaptic transmission by decreasing quantal release 
frequency or synapse density. 
 
Mint2 N723S mutant does not alter synapse ultrastructure 
To correlate synapse structure with the functional changes I found in 
synaptogenesis (Fig. 5.1A) and synaptic transmission (Fig. 5.2A), I examined the 
structure of asymmetric excitatory synapses in Mint-deficient hippocampal neurons 
infected with cre recombinase and rescued with Mint2 wild type or Mint2 N723S 
lentivirus by quantitative electron microscopy.  However, I found no significant changes 
of Mint2 N723S as compared to Mint2 wild type, suggesting that N723S does not alter 
the synapse structure of asymmetric synapses (Table. 5.3).  A previously study has shown 
no obvious difference between control and Mint deficient neurons in asymmetric 
synapses (Ho et al. 2006), suggesting that Mint2 does not have a significant role in 
synapse structure.  Also, I examined the structure of symmetric inhibitory synapses and 
found no difference between Mint2 wild type and Mint2 N723S (Table. 5.4).   
 
Mint2 CNV promotes synaptogenesis  
In the previous chapters, I found that Mint2 overexpression increases neurexin 
membrane localization in HEK293T cells (Fig. 3.1B-C) and neurexin synapse 
localization compared to the EGFP control (Fig. 4.7).  Here, I determined whether Mint2 
overexpression also promotes synapse formation in a heterologous synapse formation 
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assay with wild type neurons.  COS-7 cells expressing NL1-mVenus fusion protein as a 
postsynaptic target were co-cultured with neurons infected with lentiviral control (wild 
type) or Mint2 overexpression (Mint2 OE).  I found that Mint2 overexpression 
significantly increases synapse formation by 60% compared to the wild type control (Fig. 
5.3), suggesting that Mint2 copy number variant promotes synapse formation.  
 
Mint2 CNV promotes vesicle trafficking and docking in excitatory synapses 
Previously, our laboratory has shown that Mint2 overexpression in wild type 
neurons increases spontaneous excitatory neurotransmission (Sullivan et al. 2014).  Next, 
to correlate the changes in function to the changes in form, I determined whether Mint2 
copy number alters synaptic structure by quantitative electron microscopy of the synapses 
from cultured wild type neurons treated with either a lentiviral control or Mint2 wild type 
by quantitative electron microscopy (Fig. 5.4).  There were no obvious differences 
between control and Mint2 wild type infected neurons in presynaptic area, perimeter, 
length of postsynaptic density, and vesicle numbers 150 nm away from the active zone 
(Table 5.1).  However, I found that Mint2 wild type infected neurons had significant 
increase of the total vesicles per terminal by 30% as compared to the control (Fig. 5.4B), 
suggesting that Mint2 copy number variant may enhance vesicular trafficking to the 
presynaptic terminal.  Also, I found out that Mint2 wild type infected neurons 
significantly increases the number of docked vesicles per active zone by 30% (Fig. 5.4B), 
suggesting that Mint2 CNV indirectly promote vesicle docking and vesicular release by 
trafficking more vesicles to the presynaptic terminal.  This data is consistent with the 
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previous finding showing that Mint2 overexpression increases the frequency of 
spontaneous neurotransmitter release compared to the control (Sullivan et al. 2014).  
Overall, these data support that (1) Mint2 acts as an important regulator of presynaptic 
neurotransmitter release machinery (Biederer and Südhof 2000, Ho et al. 2006), and (2) 
Mint2 CNVs promote vesicular trafficking and vesicle docking, which may contribute to 
the imbalance in neurotransmission that is associated with autism.   
I also examined the symmetric (presumptive inhibitory) synapses and found no 
significant differences between the wild type control and Mint2 overexpression (Table 
5.2), further validating Mint2’s specific role in excitatory synapses. 
 
Discussion  
Effects of Mint N723S on synapse formation and synaptic function 
Neurexins and neuroligins are presynaptic and postsynaptic cell adhesion 
molecules that have been associated with synapse formation.  I examined whether the 
reduced neurexin membrane trafficking of Mint2 N723S found in HEK293T cells (Fig. 
3.1B-C) and in neurons (Fig. 4.7) decreases synapse formation.  The present data shows 
that Mint2 N723S reduces synapse formation in heterologous synapse formation assay 
similar to the knockout (Fig. 5.1A), suggesting that N723S may behave like a loss-of-
function mutation.  Also, Mint2 +/N723S heterozygote neurons exhibit reduced synapse 
formation similar to Mint2 knockout and Mint2 N723S neurons (Fig. 5.1A), suggesting 
that Mint2 N723S may be a dominant negative mutation.   
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To correlate the reduction in synapse formation with an altered functional change, 
I next examined whether Mint2 N723S alters excitatory synaptic transmission since 
Mint2 is preferentially localized in excitatory neurons (Ho et al. 2006).  I found that 
while N723S does not change the “mini” amplitude, it decreases the “mini” frequency 
similar to the knockout (Fig. 5.2A).  This same effect was also observed in Mint2 KO and 
ΔPDZ mutants.  Together, these data suggest that (1) Mint2 N723S is a loss-of-function 
mutation, that only effects the presynaptic neurotransmitter release machinery, and (2) 
Mint2 overexpression is a gain-of-function mutation, that effects both presynaptic and 
postsynaptic neurotransmission (Sullivan et al. 2014).   
 
Effect of Mint2 copy number variant on synapse formation and synaptic function 
As a preliminary test, I examined the effects of Mint2 overexpression on the total 
protein levels of PSD95 and synapsin by quantitative immunoblotting.  I found no 
difference between Mint2 wild type and Mint2 overexpression (data not shown), 
suggesting that Mint2 overexpression did not increase the total synapse number, which is 
consistent with previous in vivo work demonstrating that Mint2 knockout neurons did not 
alter synaptic protein expression significantly (Ho et al. 2006).  However, since Mint2 
overexpression alters spontaneous excitatory neurotransmission by increasing both the 
“mini” frequency and “mini” amplitude (Sullivan et al. 2014), one would expect Mint2 
overexpression could increase synapse density.  If there was no change in synapse 
density, the higher “mini” frequency was caused by the increased in vesicle density and 
vesicular release at the presynaptic terminal (Fig. 3.3B).   
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Alternatively, Mint2 overexpression is involved in the specialized synapse and 
not in the global regulation of synaptic proteins.  One could examine the effect of Mint2 
overexpression for excitatory synapses since Mint2 overexpression alters spontaneous 
excitatory neurotransmission (Sullivan et al. 2014). 
Finally, I examined heterologous synapse formation assay to reveal an effect of 
Mint2 on synaptogenesis since the co-cultured system offers less potentially 
compensatory mechanisms as compared to the wild type culture.  The present data show 
that Mint2 overexpression increases synaptogenesis compared to the wild type control 
(Fig. 5.3B), suggesting that Mint2 overexpression is a gain-of-function mutation.  
Together, the data indicate that (1) Mint2 is involved in synapse formation by trafficking 
neurexins to the presynaptic terminal and (2) Mint2 overexpression promotes more 
synapse formation by trafficking more neurexins to the presynaptic terminal (Fig. 4.7).  
The increase in synaptogenesis (Fig. 5.3) correlates well with the increase in 
excitatory spontaneous neurotransmission (Sullivan et al. 2014).  Overexpression of 
Mint2 increases the frequency of miniature excitatory postsynaptic current (mEPSC), 
suggesting that Mint2 copy number variant increases the frequency of presynaptic release 
probability.  Mint2 copy number variant also increases the amplitude of mEPSC, 
suggesting that Mint2 copy number variant increases the postsynaptic receptor density.  
Together, these data suggest that Mint2 overexpression has both presynaptic and 
postsynaptic effects, which is different from the Mint2 knockout and Mint2 N723S 
mutant, which only effect the presynaptic release probability (Fig. 5.2).  
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Next, I determined whether the increased in excitatory spontaneous 
neurotransmission (Sullivan et al. 2014) correlates with any structural changes of the 
synapse.  I found that Mint2 copy number variant significantly increases the total vesicles 
per terminal and the number of docked vesicles per active zone by 30% (Fig. 5.4B).  
These data strongly support that Mint2 copy number variant promotes vesicle trafficking 
to the presynaptic terminal.  However, it does not imply that Mint2 copy number variant 
promotes vesicle docking and releasing, at least not directly.  This is because since the 
increases in both measurements (total vesicles per terminal and the number of docked 
vesicles per active zone) is the same (30%) (Fig. 5.4B), hence, the increased in docked 
vesicles comes from the similar increased in vesicles concentration.  In sum, Mint2 copy 
number variant promotes more vesicle trafficking to the presynaptic terminal, and 
therefore, more vesicles are available for docking and releasing.   
 Autism is associated with an imbalance of excitatory and inhibitory inputs.  The 
present data suggest that Mint2 N723S and Mint2 ΔPDZ mutant decrease the frequency 
of excitatory transmission and may alter the precise balance between excitation and 
inhibition.  Based on the established model, Mint2 PDZ domains interact with neurexin at 
the presynaptic terminal to facilitate vesicular fusion (Biederer and Südhof 2000).  
However, this model does not fully explain my data.  Mint2 ΔPDZ mutant lacks 
interaction with neurexin (Fig. 3.1A), and therefore, it also reduces the frequency of 
spontaneous excitatory transmission (Fig. 5.2).  However, Mint2 N723S mutant exhibits 
no binding deficit to neurexin (Fig. 3.1A), but it still reduces the release frequency (Fig. 
5.2).  This suggests that Mint N723S alters synaptic transmission by a mechanism that 
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may be independent of binding to neurexin or at least not fully depend on its interaction 
with neurexin.  A possible explanation for this discrepancy is that Mint2 N723S binds to 
neurexin normally, but traffics less neurexin to the synapses.  A decrease in synapse 
formation may be an explanation for a decrease in neurotransmission, which suggests a 
lower synapse density that is responsible for the lower “mini” frequency.  
Autism spectrum disorder is a neurodevelopmental disorder that is characterized 
by impaired social interaction, aberrant language acquisition, and repetitive behavior.  An 
abnormal neuronal connectivity that leads to perturbation in information processing may 
cause autism (Herbert 2005, Polleux and Lauder 2004).  The disorder is diagnosed 
strictly on behavioral criteria and impaired social interaction is one of the key symptoms 
of autism.  It would be interesting to examine neurexin Iα or Mint2 knockout mice to see 
whether they have behavioral phenotypes that resemble the core symptoms found in 
autism.  Neurexin Iα knockout mice displayed reduced social interaction and 
spontaneous locomotor activity in novel environment (Grayton et al. 2013).  Similarly, 
Mint2 knockout mice displayed decreased intruder exploration behavior in a resident 
intruder test and lessen interest to attractive stimuli compared to wild type mice (Sano et 
al. 2009).  In addition, in vitro studies have shown that neurexin or Mint2 deficiency all 
lead to decrease in spontaneous neurotransmission (Missler et al. 2003, Kattenstroth et al. 
2004, Etherton et al. 2009).  An impaired neurotransmission can cause a network-wide 
disruption in the brain and behavioral abnormalities that are found in autism.  Here, I 
propose that Mint2 copy number variant and Mint2 N723S mutation cause aberrant 
	  	  
91	  
synapse formation and disrupt neurotransmission as plausible mechanisms that contribute 
to autism.  
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Figure. 5.1: Mint2 N723S mutant alters synaptogenesis. 
A, Mint2 N723S mutation decreases synaptogenesis in Mint-deficient (M1-/-; fM2/fM2; M3-/-) 
hippocampal neurons.  Representative images of COS-7 cells expressing NL1-mVenus fusion 
protein (green) that were cocultured with neurons to induce synapse formation (indicated by 
synapsin labeling in red).  The degree of synapse formation was determined by the co-localization 
of the presynaptic marker synapsin (red) with the postsynaptic NL1-mVenus (green).  B, 
Quantification of synapse formation of all Mint2 mutants compared to the wild type.  *p<0.05; 
*p<0.010; ***p<0.005. 
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Figure. 5.2: Mint2 N723S mutation decreases excitatory spontaneous neurotransmitter 
release in both Mint-deficient and wild type neurons.   
A, Sample traces showing mEPSC of control, Mint2 KO, Mint2 wild type, Mint2 N723S, or 
ΔPDZ mutants in Mint-deficient (M1-/-; fM2/fM2; M3-/-) hippocampal neurons.  Bar graphs 
showing that Mint2 KO, N723S, and ΔPDZ mutants significantly decrease the frequency of 
mEPSC compared to the wild type.  The mEPSC amplitude does not change significantly in all 
treatments (Control, n=9, WT, n=15; KO, n=9; N723S, n=13; ΔPDZ, n=12; *p<0.05).  B, Sample 
traces showing mEPSC of Mint2 wild type or Mint2 N723S mutant in wild type hippocampal 
neurons.  Bar graphs showing that Mint2 N723S mutant significantly decreases the frequency of 
mEPSC compared to the wild type.  The mEPSC amplitude does not change between the two 
treatments (WT, n=12; N723S, n=5; *p<0.05). 
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Figure. 5.3: Mint2 copy number variant alters synatogenesis. 
A, Mint2 copy number variant increases synaptogenesis in wild type hippocampal neurons.  
Representative images of COS-7 cells expressing NL1-mVenus fusion protein (green) that were 
cocultured with neurons to induce synapse formation (indicated by synapsin labeling in red).  B, 
Quantification of synapse formation of Mint2 copy number variant compared to the wild type 
control. 
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Figure. 5.4: Mint2 copy number variant increases vesicular trafficking and the number of 
docked vesicles in asymmetric excitatory synapses.   
A, Representative electron micrographs of asymmetric excitatory synapses of wild type control or 
Mint2 overexpressed (Mint2 OE) neurons.  B, Bar graphs showing that Mint2 overexpression 
significantly increases the vesicles per terminal and the docked vesicles per active zone compared 
to the wild type control.  *p<0,05.  Scale bar is 100 nm.  
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Table. 5.1: Quantitative ultrastructural analysis of the effects of Mint2 copy number 
variant on excitatory synapses.  
 
Parameter Wild type Mint2 OE p value 
Presynaptic terminal area (µm2) 2.22 ± 0.24 2.65 ± 0.26 p=0.225 
Presynaptic terminal circumference (µm) 3.11 ± 0.17 3.45 ± 0.15 p=0.139 
Length of postsynaptic density (µm) 0.35 ± 0.02 0.41 ± 0.03 p=0.137 
Docked vesicles per active zone 2.75 ± 0.36 3.58 ± 0.23 p=0.024* 
Vesicles 150 nm of the active zone 10.35 ± 0.7 10.8 ± 0.80 p=0.703 
Vesicles per terminal  45.05 ± 5.5 59.65 ± 4.7 p=0.025* 
 
All data are presented as means ± SEM    
n=40 cells /treatment 
*Indicates significance.    
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Table. 5.2: Quantitative ultrastructural analysis of the effects of Mint2 copy number 
variant on inhibitory synapses.  
Parameter wild type Mint2 OE p valu e 
Presynaptic terminal area (µm2) 
2.28 1.95 0.35 
Presynaptic terminal circumference (µm) 
3.53 3.32 0.54 
Length of postsynaptic density (µm) 
0.36 0.60 0.41 
Docked vesicles per active zone 
16.91 11.93 0.15 
Vesicles 150 nm of the active zone 
48.73 49.60 0.93 
Vesicles per terminal 
22.02 25.51 0.34 
 
 
All data are presented as means ± SEM    
Wild type, n=11; Mint2 OE, n=15.  
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Table. 5.3: Quantitative ultrastructural analysis of the effects of Mint2 N723S mutant on 
excitatory synapses.  
Parameter Wild type N723S  p value 
Presynaptic terminal area (µm2) 2.38 ± 0.19 2.92 ± 0.3 p=0.116 
Presynaptic terminal circumference (µm) 3.13 ± 0.15 3.41 ± 0.21 p=0.163 
Length of postsynaptic density (µm) 0.31 ± 0.02 0.34 ± 0.02 p=0.251 
Docked vesicles per active zone 2.03 ± 0.23 2.04 ± 0.28 p=0.983 
Vesicles 150 nm of the active zone 7.5 ± 0.53 7.89 ± 0.48 p=0.598 
Vesicles per terminal 49.18 ± 4.4 65.56 ± 7.8 p=0.059 
Vesicle density 23.15 ± 2.0 23.41 ± 1.9 p=0.926 
 
 
All data are presented as means ± SEM    
Wild type, n=34; N723S, n=27.     
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Table. 5.4: Quantitative ultrastructural analysis of the effects of Mint2 N723S mutant on 
inhibitory synapses.  
Parameter Wild type N723S  p value 
Presynaptic terminal area (µm2) 2.38 ± 0.33 3.00 ± 0.37 p=0.223 
Presynaptic terminal circumference (µm) 3.08 ± 0.27 3.45 ± 0.22 p=0.298 
Docked vesicles per active zone 1.43 ± 0.31 1.54  ± 0.35 p=0.816 
Vesicles 150 nm of the active zone 6.29 ± 0.57 8.23 ± 0.57   p=0.023* 
Vesicles per terminal 39.14 ± 5.7 52.85 ± 5.2  p=0.091 
Vesicle density 18.50 ± 2.2 18.75 ± 1.7  p=0.932 
 
 
All data are presented as means ± SEM    
Wild type, n=14; N723S, n=13. 
*Indicates significance.    	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CHAPTER SIX: Thesis research summary and future directions 
 
Thesis research summary 
Autism spectrum disorder  (ASD) is a neurodevelopmental disorder with strong 
genetic associations.  Mutations in the human MINT2 gene that encodes for a neuronal 
adaptor protein have been genetically-linked to autism patients.  The MINT2 gene maps 
to the distal portion of chromosome 15q13.1, a region that is commonly deleted in 
Prader-Willi and Angelman syndromes and duplicated in cases of autism, making MINT2 
an attractive candidate gene associated with autism.  Copy number variants in the MINT2 
gene have been associated with autism (Babatz et al. 2009).  Also, seven novel 
nonsynonymous coding variants in Mint2 in ASD subjects have been identified.  Five of 
the seven unique ASD Mint2 variants were predicted to affect protein function; however, 
these variants have not been examined functionally.  
 Mint2 belongs to the Mint family of neuronal proteins that are important for 
synaptic function.  The multi-domain structure and the nature of their interacting partners 
determine the function of the Mints. Mint2 interacts directly with neurexin-Iα (NRXN1), 
an ASD gene, as part of a multi-protein complex that acts as a facilitator of 
neurotransmitter release.  The goal of my work is to understand the biology of Mint2 and 
its potential contribution in the pathogenesis of ASD.  I hypothesized that Mint2 is 
important for neuronal development and that Mint2 copy number and sequence variants 
contribute to neuronal dysfunctions that are associated with autism.  For this project, I 
came up with the following three aims.  
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First, I determined whether Mint2 copy number and sequence variant N723S alter 
neuronal development.  I found that while Mint2 copy number variant (a gain-of-function 
mutation) increases neuronal growth, Mint2 N723S (a loss-of-function mutation) 
decreases neuronal growth, suggesting that Mint2 is involved in neuronal development.  
Second, I found that Mint2 wild type in involved in neurexin I membrane 
localization and synapse targeting.  Also, I found that while Mint2 N723S binds to 
neurexin normally, it decreases neurexin membrane localization in HEK293T cells and 
neurexin I synapse targeting in neurons.  Together, these data reveal a novel function of 
Mint2 in neurexin membrane localization and the altered membrane localization resulted 
from Mint2 N723S could lead to neuronal dysfunction. 
Third, I determined whether Mint2 copy number variant and Mint2 N723S alter 
synapse formation and synaptic function.  I found that while Mint2 copy number variant 
promotes synapse formation, Mint2 N723S decreases synapse formation.  Previously 
publication from the lab has shown that Mint2 copy number variant increases excitatory 
spontaneous neurotransmission.  In contrast, I found that Mint2 N723S decreases 
excitatory spontaneous neurotransmission.  In sum, this study suggests that Mint2 copy 
number and sequence variant N723S disrupt synapse formation and synaptic transmission 
that are associated with ASD pathogenesis.  The validation and mechanistic role of new 
genes such as MINT2 associated with ASD will directly lead to a better understanding of 
the molecular pathways critical for diagnosis of ASD and may improve prognosis and lay 
the foundation for novel therapeutic approaches. 
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In this thesis, I have examined both Mint2 copy number and sequence variant 
Mint2 N723S in neuronal development (Chapter 3) and neuronal function (Chapter 4 and 
5).  Copy number variants are the duplication or deletion of DNA, which leads to more or 
less genetic material, respectively.  In this study, I have examined both types of copy 
number variants in Mint2.  First, Mint2 copy number variant (duplication of genetic 
material) is mimicked by Mint2 overexpression in wild type neurons.  Second, Mint2 
copy number variant (deletion of genetic material) is mimicked by Mint2 knockout in 
Mint-deficient neurons.  All, I have examined the effect of Mint2 sequence variant 
N723S in Mint2-deficient neurons.  It is important to note that Mint2 N723S behaves like 
a Mint2 knockout in functional neuronal experiments, including neuronal development 
(Chapter 3), synaptogenesis (Chapter 5), and neurotransmission (Chapter 5).  In 
summary, Mint2 N723S and Mint2 knockout are loss-of-function mutations whereas 
Mint2 copy number variant (Mint2 overexpression) is a gain-of-function mutation, and 
both of them can contribute to deficits in neuronal development and synaptic function.   
 
Future directions 
Identify Mint2-neurexin trafficking complex 
This thesis has covered an extensive array of in vitro studies in both HEK293T 
cells and primary mouse neurons with techniques ranging from biochemistry, cell 
biology, live cell imaging, and electrophysiology.  Many of these techniques are standard 
and widely used in the synaptic field.  In addition to what has been done, few interesting 
questions still required further investigation.  
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First, it would be interesting to decipher the Mint2-neurexin trafficking complex.  
Previously it was shown that the first PDZ domain of Mint1 interacts directly with 
kinesin superfamily motor protein KIF17 to traffic NMDA receptor-containing vesicles 
in the dendrites (Setou et al. 2000).  Since the PDZ domains are highly conserved within 
Mints, Mint2 could interact with KIF17 in principle.  To determine whether Mint2 
interacts with KIF17 directly, I could co-immunoprecipitate Mint2 and KIF17 in 
HEK293T cells and in wild type neurons.  For HEK293T cells, I could 
immunoprecipitate for Mint2 and immunoblot for KIF17.  For wild type neurons, I could 
immunoprecipitate for Mint2 and immunoblot for KIF17 and neurexin, which would 
determine whether these proteins are associated together. 
One can also use GST pull down as an alternative approach to study Mint2 and 
KIF17 interaction in both HEK293T cells and wild type neurons.  For this experiment, a 
bacterial expression GST fusion protein that expresses the cytoplasmic tail of neurexin I 
to test whether neurexin could pull down Mint2 and KIF17.  
In addition to the biochemical analyses described above, I could perform 
immunocytochemistry experiments to validate Mint2, neurexin, and KIF17 interaction in 
neurons.  Since there is no neurexin antibody available for immunostaining, mCherry-
neurexin plasmid must be transfected into neurons.  The endogenous Mint2 and KIF17 
can be labeled with commercially available antibodies to determine whether all three 
proteins co-localized together, which would suggest interaction.  
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Lastly, one could investigate the developmental expression of KIF17, Mint2, and 
neurexin in brain lysate.  Brain lysates from wild type pups are immunoblotted with 
antibodies against endogenous KIF17, Mint2, and neurexin to determine whether they are 
showing a similar temporal expression during development.  Co-expression would 
indicate co-regulation.   
Mint1 was identified as the receptor for KIF17 by yeast two-hybrid screening 
(Setou et al. 2000).  It is important to keep in mind that KIF17 may not be the motor 
protein that is involved in Mint2-mediated neurexin trafficking.  There is a fundamental 
difference between Mints 1 and 2 vesicular transport.  For Mint1, Kif17 is involved in the 
transport (anterograde) of NMDA receptor subunit in the dendrites.  For Mint2, I focused 
on neurexin transport (anterograde) in the axon.  Because of the difference in location 
(dendrite vs. axon), the same motor protein may not apply.  If all the above experiments 
failed, one should seek other methods (e.g., proximity ligation assay or chemical 
crosslinking with co-immunoprecipitation) to identify potential protein interactions in 
neurons.   
 
Live cell imaging of GFP-Mint2 and mCherry-Neurexin 
When I first found that Mint2 could be involved in neurexin membrane 
trafficking, the initial goal was to visualize Mint2 and neurexin interaction in live 
neurons.  However, I was not able to visualize the mCherry signals in live cells due to the 
limitation of our microscope.  For this study, I bypassed the limitation by amplifying the 
mCherry signals with a rabbit anti-mCherry antibody in fixed neurons.  However, it 
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would be informative to visualize Mint2 and neurexin trafficking in live neurons if the 
technology allows.  
 
Decipher the function of Mint2 in Golgi  
The synaptic functions of Mint2 have been well studied in the literature.  
However, Mint2 is predominately localized in the neuronal Golgi (Biederer et al. 
2002)—also see Fig. 4.6.  It is speculated that Mint2 is involved in vesicle trafficking 
(Biederer et al. 2002).  However, the exact function of Mint2 in the Golgi is not clear and 
requires further investigation, which could reveal a novel function.  Also, the two PDZ 
domains clearly are essential for Mint2 Golgi targeting.  It would be interesting to 
determine their function in Golgi targeting. Mint3 also has two PDZ domains like Mints 
1 and 2.  Mint3 is ubiquitously expressed throughout the body.  Therefore, it is possible 
to learn about the Golgi function by using Mint3 as a tool.  
 
Mint2 dimer 
At the present moment, it is not clear whether Mint2 is monomeric, dimeric, or 
multimeric.  Based on the effects of Mint2 N723S heterozygous mutant on axon 
development, synapse formation, and neurotransmission, I speculated that Mint2 N723S 
could be a dominant negative mutation, which strongly suggests that Mint2 proteins can 
dimerize.  Mint2 N723S binds to Mint2 wild type and inhibits its function.  To test this 
hypothesis, co-immunoprecipitation experiment of Mint2 wild type and Mint2 N723S 
	  	  
107	  
was performed to determine the potential interaction between them.  However, co-
immunoprecipitation does not show direct interaction, as there could be other mediators 
involved.  I also tried to visualize Mint2 dimer with native gel electrophoresis.  Although 
a 260 kDa Mint2 band (approximately the size of Mint2 dimer) was visible, the Mint2 
monomeric band was not visible (maybe due to the small abundance of Mint2 
monomers).  The data would be more convincing if both Mint2 dimeric and monomeric 
bands are visible in the native gel.  
 
Generate and characterize Mint2 N723S knock-in mice 
While using Mint conditional knockout mice (Ho et al. 2006, Ho et al. 2008) to 
study the effects of Mint2 N723S mutation is a simple and an elegant strategy, it is not 
sufficient to represent the physiological condition of the patient.  Moreover, experiments 
with neuronal cultures only allow in vitro studies.  To further investigate the effects of 
Mint2 N723S in vivo, Mint2 N723S knock-in mice should be generated as a tool.  There 
are myriad of experiments that could be done to characterize Mint2 N723S knock-in 
mice.  First, one could examine the synaptic transmission from cultured brain slices to 
monitor spontaneous miniature postsynaptic currents (minis) and evoked synaptic 
transmission.  Second, one could analyze the morphology of the synaptic structure to 
determine the effects of Mint2 N723S.  Third, one could perform quantitative protein 
analysis of neuronal proteins by Western blotting and imaging.  Lastly, since deficit in 
social interaction is one of the core criteria for autism diagnosis, it would be important to 
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test whether Mint2 N723S knock-in mice display similar phenotypes that are associated 
with autism.  
.
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APPENDIX  
 
A1.1 Mint2 ASD mutants do not alter Mint2 cellular localization 
Although Mint2 ASD mutations do not alter Mint2 protein expression in Western 
blotting analysis (Fig. A1.1), Mint2 ASD mutants may still be mislocalized in cells 
without any expression deficit.  To investigate this possibility, I next determined whether 
Mint2 ASD mutants alter Mint2 localization.  HEK293T cells were transfected with 
GFP-tagged Mint2 wild type, Mint2 R4Q, Mint2 T660M, or Mint2 N723S on coverslips.  
These mutants were selected based on their differential binding to APP (Fig. 3.2B-C).  48 
h after transfection, coverslips were fixed, mount, and imaged.  The data showed that 
Mint2 wild type has an even cytosolic localization (Fig. A1.1).  There was no obvious 
difference between the mutations compared to the wild type, suggesting that they do not 
alter Mint2 localization in HEK293T cells.  It is important to note that some phenotypes 
may not be visible in HEK293T cells because these cells are not neuronal and lacking 
other neuronal proteins that are essential for Mint2 function.  For example, HEK293T 
cells transfected with Mint2 wild type alone does not show Golgi localization.  In 
contrast, primary neurons infected with Mint2 wild type lentivirus does show a Golgi 
localization.  
 
A1.2 Mint2 ASD mutants do not alter co-localization with APP  
Based on co-immunoprecipitation experiments, three Mint2 ASD mutants (R4Q, 
T660M, and N723S) altered binding to APP (Fig. 3.2B-C).  To determine whether altered 
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interaction also leads to altered APP localization, I examined APP and Mint2 co-
localization in HEK293T cells.  APP was transfected together with GFP-tagged Mint2 
wild type, Mint2 R4Q, Mint2 T660M, or Mint2 N723S.  48 h after transfection, 
coverslips were fixed and stained for APP.  The data revealed that Mint2 wild type and 
APP co-localize in vacuoles (Fig. A1.2), which is different from Mint2 wild type 
transfection alone (Fig. A1.1).  However, none of the ASD mutants displayed any 
obvious difference compared to the wild type.  
 
A1.3 Mint2 and APP-containing vacuoles are localized to lysosome and 
autophagosome  
To further characterize the identity of Mint2 and APP-containing vacuoles, APP 
was transfected together with GFP-Mint2 wild type and stained for various organelle 
markers.  The data revealed that Mint2 and APP-containing vacuoles are localized to 
either lysosome or autophagosome (Fig. A1.3).   
 
A1.4 Mint2 form tripartite complex with APP and Munc18-1 
A previous study found that Mint2, APP, and Munc18-1 form a tripartite complex 
in both co-immunoprecipitation and Bimolecular Fluorescence Complementation (BIFC) 
assays (Weyer et al. 2011).  To reproduce this finding, I transfected GFP-Mint2 wild 
type, APP, and Munc18-1 (in equal ratio) into HEK293T cells.  48 h after transfection, 
cells were labeled for APP and Munc18-1.  The data revealed that Mint2, APP, and 
Munc18-1 co-localized into vacuoles (Fig. A1.4). 
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Figure A1.1: Mint2 ASD mutants do not alter Mint2 cellular localization in HEK293T cells. 
Representative images of HEK293T cells transfected with GFP-Mint2 wild type (WT), Mint2 
R4Q, Mint2 T660M, or Mint2 N723S.   
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Figure A1.2: Mint2 ASD mutants do not alter colocalization with APP in HEK293T cells.   
Representative images of HEK293T cells transfected with APP with GFP-Mint2 wild type (WT), 
Mint2 R4Q, Mint2 T660M, or Mint2 N723.   
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Figure A1.3: Mint2 and APP-containing vacuoles are localized to autophagosome and 
lysosome in HEK293T cells. 
Representative images of HEK293T cells transfected with GFP-Mint2 wild type (WT) and APP.  
Cells were fixed and stained with antibodies against LAMP (an autophagosome marker) or LC3 
(a lysosome marker).  Note that the APP staining is not shown here.   
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Figure A1.4: Mint2 forms tripartite complex with APP and Munc18-1 in HEK293T cells. 
Representative images of HEK293T cells transfected with GFP-Mint2 wild type (WT), APP (in 
red), and Munc18 (in pink).  Cells were fixed and stained with antibodies against APP and 
Munc18. 
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